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Abstract 
Activated by elevations in myoplasmic calcium concentration, myosin light chain 
kinase (skMLCK) phosphorylates the regulatory light chains (RLCs) of fast muscle 
myosin. This covalent modification potentiates force production, but requires an 
investment of ATP. Our objective was to investigate the effect of RLC phosphorylation 
on the contractile economy (mechanical output:metabolic input) of fast twitch skeletal 
muscle. Extensor digitorum longus muscles isolated from Wildtype and skMLCK-/- mice 
mounted in vitro (25°C) were subjected to repetitive low-frequency stimulation 
(10Hz,15s) known to cause activation of skMLCK, and staircase potentiation of force. 
With a 3-fold increase in RLC phosphate content, Wildtype generated 44% more force 
than skMLCK-/- muscles over the stimulation period (P = .002), without an accompanied 
increase in energy cost (P = .449). Overall, the contractile economy of Wildtype muscles, 
with an intact RLC phosphorylation mechanism, was 73% greater than skMLCK-/- 
muscles (P = .043), demonstrating an important physiological function of skMLCK 
during repetitive contractile activity. 
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1. Introduction 
Skeletal muscle is a biological motor that functions to convert chemical energy 
into mechanical energy. The main contractile components of muscle are actin and 
myosin, which polymerize to form the thin and thick filaments, respectively (Huxley, 
1957). Myosin also plays an important enzymatic role in muscle, as it is an ATPase 
capable of producing motility by moving actin (Rayment & Holden, 1994). Chemical 
energy is converted into mechanical energy via myosin crossbridges during their cyclical 
interactions with actin, referred to as crossbridge cycling, which results in filament 
sliding and the production of force (Lymn & Taylor, 1971).  
The myosin molecule is a hexamer composed of two heavy chains, and two pairs 
of light chains (Rayment, Rypniewski, et al., 1993b). The regulatory light chain (RLC) of 
myosin exists non-covalently bound to the myosin heavy chain, and is responsible for 
performing both a stabilizing and regulatory role (Alamo et al., 2008). A rise in 
intracellular calcium concentration, the same signal that initiates muscle contraction, 
leads to activation of the enzyme skeletal myosin light chain kinase (skMLCK) which 
catalyzes the phosphorylation of the myosin RLC (Stull, Kamm, & Vandenboom, 2011). 
This phosphotransferase activity introduces a negative charge to the RLC, and through 
myosin head-rod interactions causes a mass movement of myosin heads off the thick 
filament backbone, projecting them towards the actin filament, increasing the likelihood 
of actin-myosin interaction (Duggal et al., 2014). This phosphorylation-induced loss of 
helical ordering increases the number of crossbridges in the force producing state, 
modulating the calcium sensitivity of the contractile apparatus; thus, potentiating force 
production and the hastening the rate of force development (Stull et al., 2011).  
This phenomenon is known as RLC phosphorylation-mediated force potentiation, 
and can greatly increase force, work, and power (Vandenboom, Gittings, Smith, Grange, 
& Stull, 2013). Although RLC phosphorylation requires a continual investment of ATP, 
it results in a dramatic increase in submaximal force output across a range of intracellular 
calcium concentrations, i.e. with no increased energy cost of calcium handling. 
Therefore, if RLC phosphorylation is able to augment the relationship between the total 
energy consumed during contraction, and the force produced, it may play an important 
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role in determining the contractile economy (i.e. mechanical output:metabolic input) of 
fast twitch skeletal muscle.  
To date, no one has attempted to quantify the “energetic overhead” associated 
with skMLCK-mediated RLC phosphorylation in mammalian skeletal muscle, although 
Homsher (1987) predicted that the ATP consumed for this process is upwards of 5% of 
the energy used during a 5 second tetanus. Early research did attempt to investigate the 
relationship between RLC phosphorylation and energy consumption during contraction; 
however, no consensus has been reached. One of the earliest studies attempting to answer 
this research question reported a correlation between RLC phosphorylation and a reduced 
energy cost for isometric tetani (Crow & Kushmerick, 1982b). Subsequently, Barsotti and 
Butler (1984) found that RLC phosphorylation had no consistent relationship with the 
energy consumed during stimulation. Most recently, Abbate, Velden, Stienen, and De 
Haan (2001) stated that potentiation increased the energetic cost of contraction to a larger 
extent than work. Thus, previous results were equivocal and contradictory, and this 
question remains one of the most interesting in our field. One could argue that the vast 
differences between the findings of previous studies are attributable to the differing 
stimulation paradigms; however, the most glaring limitation of all previous work is the 
lack of a proper negative control for RLC phosphorylation. Any skeletal muscle 
contraction, no matter how brief, will result in fractional activation of skMLCK, and lead 
to the phosphorylation of myosin RLCs. Fortunately, a group of researchers developed a 
unique skMLCK knockout model by ablating the gene coding for skMLCK from 
C57BL/6 mice (Zhi et al., 2005). Our lab at Brock University is currently the only 
institution with a colony of skMLCK devoid (skMLCK-/-) mice, affording us the unique 
opportunity of using a robust negative control to explore this unresolved conflict.  
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2. Review of Literature 
This literature review was completed in preparation for an experiment exploring 
the potential relationship that exists between  myosin RLC phosphorylation and the 
metabolic cost of muscle contraction. The first section of the review, entitled Skeletal 
Muscle Structure and Function, explores the key structural and functional aspects of 
mammalian skeletal muscle, touching on microanatomy and organization of the 
sarcomere, with a description of the main structural and functional proteins that form the 
macromolecular machine. An overview of both Excitation-Contraction Coupling and the 
Crossbridge Cycle follow, in an attempt to quickly familiarize the reader with the 
processes that initiate, regulate, and actuate contraction of skeletal muscle. A basic 
understanding of skeletal muscle anatomy, and the mechanisms that govern its ability to 
produce force and/or work will benefit the discussions of the interaction of RLC 
phosphorylation, force potentiation, and metabolism that follow. 
The next major section of the review explores modulation of the contractile 
apparatus by the phenomenon of Myosin Regulatory Light Chain Phosphorylation. Here, 
focus is given to the enzymes that regulate myosin RLC phosphorylation, and the 
remarkable physiological utility of this covalent modification. Significant discoveries 
within in the field of RLC phosphorylation-mediated force potentiation of fast-twitch 
skeletal muscle are examined. The way in which this phosphate-incorporation modulates 
the interaction between the proteins responsible for contraction is explored using the 
framework of the Brenner Two-State Model.   
Metabolic Considerations of Mammalian Skeletal Muscle considers the principle 
reactions that harness the energy released during ATP hydrolysis to perform biological 
work during skeletal muscle contraction, the potential sources of ATP resynthesis during 
muscular activity, and the pathways responsible for maintaining the energy balance 
within the cell. Special focus is given to anaerobic ATP production via substrate-level 
phosphorylation, exploring the mechanisms and importance of the creatine kinase 
reaction, the adenylate kinase and AMP deaminase reactions, the glycolytic pathway, and 
the lactate dehydrogenase reaction. The metabolism section concludes with a look into 
the mechanical efficiency of skeletal muscle, and the economy of contraction. 
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Properties of RLC phosphorylation-mediated force potentiation and energetic 
aspects of muscle contraction are amalgamated in the final major chapter of the review, 
entitled The Metabolic Consequences of Potentiation. All relevant publications dedicated 
to exploring the relationship between potentiation and metabolism, albeit small in 
number, are discussed. Previous research has been unable to reach an agreeable 
conclusion, leaving the question largely unanswered; thus, all major possible 
relationships and theoretical explanations are considered. 
2.1. Skeletal Muscle Structure and Function 
Vertebrate skeletal muscle is a truly fascinating piece of biological machinery. 
The function of skeletal muscle is to generate force and/or produce movement, and is 
mechanically designed with tightly packed, remarkably organized contractile elements to 
achieve these goals with extraordinary efficiency. The fundamental contractile unit of 
skeletal muscle is the sarcomere, a highly ordered multi-protein complex containing 
partially interdigitating arrays of thick and thin filaments (Craig & Padrón, 2004; Craig & 
Woodhead, 2006). Sarcomeres are intricate structures containing an assortment of 
contractile, regulatory, and structural proteins that govern its structural regularity. This 
collection of proteins allows skeletal muscle to activate in milliseconds, shorten rapidly, 
and transduce chemical energy to mechanical energy (Craig & Padrón, 2004).  
Each sarcomere (Figure I) is demarcated at each end by what appears in electron 
micrographs as a dark, narrow line referred to as the Z-line - or more appropriately, the 
Z-disc. These Z-discs fall at the centre of a relatively lighter I-band (isotropic), which is a 
section shared between adjacent sarcomeres. At the heart of each sarcomere is the M-line 
that bisects the H-zone, a less dense region inside of a darker band known as the A-band 
(anisotropic). The characteristic appearance of each band is due to areas of partial of 
overlap between thin and thick filaments (Huxley & Hanson, 1954).  
The thick filaments, 110 Å in diameter, are anchored at the M-line and protrude 
outwards, while the thin filaments, 40 Å in diameter, are connected to the Z-discs and 
project inwards toward the centre of the sarcomere (Huxley & Hanson, 1954). The thin 
filaments run longitudinally from their attachment sites at the Z-disc, through the I-band 
into the A-band where they partially overlap with the thick filaments. The A-band is the 
densest region of the sarcomere due to the overlap between thick and thin filaments. The 
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lighter H-zone at its centre contains only thick, while the I-band contains only thin 
filaments. The H-zone is less dense than the rest of the A-band owing to the absence of 
overlapping thin filaments 
The process of converting chemical energy into mechanical energy is 
accomplished via myosin crossbridges during their cyclic interactions with actin 
filaments (Barclay, 1996). The sliding filament model of contraction, states that the thick 
and thin filaments themselves remain constant in length, while the shortening of muscle 
is explained by sliding of the overlapping filaments past each other (Huxley & Hanson, 
1954). Therefore, with filament length held constant, shortening of the sarcomere is 
associated with decrease in the length of the I-band (Huxley & Hanson, 1954). Actin and 
myosin are the main contractile proteins that polymerize into the thin and thick filaments 
respectively, accounting for more than 70% of myofibrillar protein (Craig & Padrón, 
2004).  
 
Figure I. Schematic representation of sarcomeric structure and organization.  
2.1.1. Myosin 
Myosin II plays an important structural and enzymatic role in muscle contraction 
and is the major constituent of the thick filament. It is a member of the myosin protein 
superfamily capable of producing motility by moving actin, and is an adenosine 
triphosphatase (ATPase). Myosin is a highly asymmetrical molecule, composed of two 
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globular heads attached to an elongated tail (Rayment & Holden, 1994). The native 
myosin II molecule of skeletal muscle has a molecular weight of 520 kDa, existing as a 
hexamer composed of two 220 kDa myosin heavy chains (MHCs) and two pairs of 
myosin light chains (MLCs) between 15 and 22 kDa (Rayment et al., 1993b). The 
carboxy (C)-terminals of the MHCs form an α-helical tail that twist around each other 
forming a coiled-coil, while the amino (N)-terminal of each MHC associates with one of 
each chemically distinct MLCs to form an elongated globular head region (Craig & 
Woodhead, 2006; Winkelmann, Baker, & Rayment, 1991).  The head of the myosin 
molecule is the motor domain responsible for both actin-binding and ATP hydrolysis, 
while the C-terminal tail is mainly responsible for dimerization of heavy chains and thus 
the formation of the thick filament backbone (Krendel & Mooseker, 2005).  
Controlled enzymatic digestion produces distinctive fragments of the myosin 
molecule (Figure II), and aids our understanding of the roles of the various domains. The 
first fragment to be considered, cleaved by trypsin, is light meromyosin (LMM): The α-
helical tail that accounts for the distal two-thirds of the myosin molecule. The remaining 
one-third of the myosin molecule, heavy meromyosin (HMM), is composed of the two 
globular heads and a shorter section of tail. Alternatively, limited papain digestion 
isolates the two myosin heads, or subfragment 1 (S1), from the myosin rod. The myosin 
rod is the isolated myosin tail, and is composed of LMM and subfragment 2 (S2) of 
HMM (Sweeney & Houdusse, 2010). 
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Figure II. Myosin subfragments created by enzymatic digestion.  
2.1.2. S1 Fragment 
The proteolytic fragment S1 is comprised the first 843 residues of the MHC, in 
addition to the two light chains; it is the morphological crossbridge and contains all of 
the enzymatic activity of myosin (Preller & Holmes, 2013). The heavy chain portion of 
the S1 comprises three domains: A 50 kDa domain at the N-terminal, a centrally located 
25 kDa domain, and a 20 kDa domain at the C-terminal that associates with two light 
chains and creates a junction with the tail. The motor domain is composed of the 50 kDa 
and 25 kDa domains, and is responsible for both binding to actin and hydrolyzing ATP. 
The rest of the head, referred to as the light chain domain or the neck region, containing 
the 20 kDa heavy chain enveloped by the RLC and ELC, functions as a lever arm 
(Sweeney & Houdusse, 2010) that translates local conformational changes to large scale 
movements (Preller & Holmes, 2013). 
2.1.3. The Thin Filament 
To form the thin filament, actin monomers, known as globular (G)-actin (~42 
kDa), self-associate into fibrillar (F)-actin. Two strands of F-actin then twist around each 
other, forming an elongated helical chain (Koubassova & Tsaturyan, 2011). The 
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contractile apparatus is regulated by the thin-filament protein complex Troponin (Tn) and 
Tropomyosin (Tm), which are attached at regular intervals along the F-actin backbone. 
These two molecules respond to changes in the intracellular concentration of calcium 
(Ca2+), and together govern the actin-myosin interaction. Thus, Tm and Tn are the 
proteins responsible for regulation of both muscular contraction and relaxation 
(Koubassova & Tsaturyan, 2011).  
Tm is a coiled-coil protein, formed by two helices of 65 kDa that join end-to-end 
or head-to-tail to form long helical rods strands along the helices of F-actin (Dominguez, 
2011; Koubassova & Tsaturyan, 2011). Tm functions to stabilize the thin filament, and 
provides molecular scaffolding for the positioning of the Ca2+-sensitive Tn molecule. Tm 
is associated with seven actin monomers, and during thin filament activation, Tm 
displays remarkable conformational plasticity by translocating across the surface of F-
actin, exposing the myosin binding sites. This molecule functions as a gatekeeper by 
controlling myosin’s access to the thin filament (Dominguez, 2011). Tn is an 80 kDa 
molecular complex that attaches at regular intervals to specific sites on Tm, and consists 
of three non-covalently linked subunits: The tropomyosin-binding (TnT), inhibiting (TnI) 
and Ca2+-sensor (TnC) subunits (Craig & Padrón, 2004).  
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2.2. Brief Overview of Excitation-Contraction Coupling 
The term Excitation-Contraction Coupling (ECC), depicted in Figure III, was 
originally coined by Alexander Sandow and refers to a series of events linking 
depolarization of the sarcolemma to the release of Ca2+ from the sarcoplasmic reticulum 
(SR), resulting in muscular contraction (Sandow, 1952). When force is to be produced, an 
action potential is initiated and propagated down a motor neuron, and crosses the 
neuromuscular junction. The action potential then propagates along the plasma 
membrane, followed by a radial spread of the potential across the sarcolemma. This wave 
of depolarization is taken into the muscle cell via membrane invaginations called 
transverse (t)-tubules (Franzini-Armstrong & Porter, 1964). The tight connection that 
exists between the t-tubule system and the flanking terminal cisternae of the SR on either 
side was dubbed a triad (Porter & Palade, 1957). This functional grouping acts as a 
junction between external and internal membrane systems, ensuring that every section of 
the muscle fibre is within 1 µm of a membrane that is continuous with the sarcolemma 
(Dulhunty, 2006).   
Communication between the t-tubules and SR occurs at specific structures called 
calcium release units (Franzini-Armstrong & Protasi, 1997), involving dihydropyridine 
receptors within the t-tubule, and ryanodine receptors embedded within the SR membrane 
(Block, Imagawa, Campbell, & Franzini-Armstrong, 1988). Dihydropyridine receptors 
(DHPRs) are calcium channels that consist of 5 subunits: the transmembrane 𝛼! subunit, 
the 𝛾  and 𝛿  subunits found associated with the membrane, the 𝛼!  subunit which is 
disulphide linked to the 𝛿  subunit, and the intracellular 𝛽  subunit (as reviewed by 
Rebbeck, Karunasekara, & Board, 2014). The 𝛼!  subunit is the principle functional 
subunit of the DHPR and functions as a voltage-gated ion channel (Leong & MacLennan, 
1998).  
The ryanodine receptors (RyRs) (Pessah, Waterhouse, & Casida, 1985) are the 
channels through which Ca2+ is released from the SR (Imagawa, Smith, Coronado, & 
Campbell, 1987). They exist as a homotetramer, with 4 equal subunits of 565 kDa, whose 
hydrophobic sections form a base that spans the SR membrane, and hydrophilic segments 
form a cytoplasmic domain bridging the gap between t-tubular membrane and SR 
membrane (Tupling, 2009).  
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DHPR-mediated detection of changes in plasma membrane potential lead to 
allosteric interactions between DHPRs and RyRs, facilitating an efflux of Ca2+ from the 
SR, and a transient elevation of the intracellular calcium concentration ([Ca2+]i) in the 
myoplasm (Leong & MacLennan, 1998; MacIntosh, Holash, & Renaud, 2012). Ca2+ ions 
diffuse, activating both myoplasmic Ca2+ buffering systems and the contractile apparatus. 
Several of the buffers that complex with Ca2+ include myosin ATPase, parvalbumin, 
sarco-endoplasmic reticulum calcium-ATPase (SERCA), and most importantly for 
excitation-contraction coupling, TnC (Baylor & Hollingworth, 2011).  
Essentially, the electrical signal brings about a rise in [Ca2+]i, allowing Ca2+ to 
modulate the position of Tm on F-actin through its interaction with the Tn complex. At 
low [Ca2+], TnI locks Tm in a position on F-actin where it obstructs the myosin-binding 
site, thus preventing contraction. When Ca2+ binds to TnC, Tm moves on the actin 
filament, exposing the myosin-binding site (Behrmann et al., 2012). Within milliseconds 
the Ca2+-Tn interaction eliminates the stearic inhibition imposed by TnI and Tm on the 
actin-myosin interaction, allowing the myosin head to bind to the now exposed myosin-
binding site on actin. Binding forms a functional structure known as a crossbridge that 
can perform a power stroke, ultimately shortening the sarcomere and/or developing 
tension (Ebashi, 1991). During relaxation, the disappearance of Ca2+ from the myoplasm 
is mediated by its movement to the mitochondria, its transport by Na+/Ca2+ exchanger 
(NCX) and its final reuptake into the SR through SERCA (Calderón, Bolaños, & Caputo, 
2014). 
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Figure III. Key proteins involved in excitation-contraction coupling. 
 
2.2.1. The Intracellular Calcium Transient 
The quanta of Ca2+ released from the SR during ECC leads to a temporary 
increase in myoplasmic [Ca2+], referred to as an intracellular calcium transient (ICT). 
The amplitude and duration of the ICT is of fundamental importance to understanding 
muscle contraction because it directly determines the level of force generated and the 
amount of energy consumed by the muscle fibre, while also communicating with various 
downstream targets including enzymes and messenger proteins (Barclay, 2012; Chin, 
2010). The rate of Ca2+ release from SR may be over 200 µmol/ms in fast twitch 
mammalian fibres, causing myoplasmic free calcium concentration ([Ca2+]free) to reach as 
high as 20 µM from a resting value of 100 nM (Baylor & Hollingworth, 2003) -  a 200-
fold increase. Incredibly, the maximum [Ca2+]free is only a small fraction of the total Ca2+ 
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that is released, as a great deal of Ca2+ is buffered by binding to a variety of intracellular 
molecules. 
2.2.2. Cooperativity 
The ratio of the number of crossbridge cycles completed, to the number of TnC 
molecules complexed with Ca2+ provides information about cooperativity between Ca2+ 
binding and crossbridge attachment along the thin filament (Gordon, Homsher, & 
Regnier, 2000) and gives insight into the basis of the difference in energy expended on 
activation processes in fast and slow twitch muscle. Barclay (2012) suggests that rather 
than a single crossbridge cycle being performed for each molecule of TnC occupied by 
Ca2+, binding of Ca2+ may actually facilitate the attachment of 1.7 crossbridges, on 
average. This is evidence of the phenomenon of cooperativity, in which binding of Ca2+ 
by TnC, inhibits stearic blocking of myosin-binding sites and allows attachment of a 
crossbridge, which itself facilitates the binding of another crossbridge without further 
Ca2+ binding. Ultimately, cooperativity increases thin filament activation without an 
increased cost of Ca2+ pumping (Gordon et al., 2000). Cooperativity is a likely a reason 
that inactivation of Ca2+ release occurs when a muscle fibre is stimulated twice within a 
short interval. During inter-pulse intervals under 100 ms, less Ca2+ is released in response 
to the second stimulus than in response to the first (Barclay, 2012). For example, 
according to in situ experiments, the motor unit firing rate that produces near-maximum 
force in fast twitch muscles from mouse hind-limbs is ~66 Hz (Manuel & Heckman, 
2011). A stimulation frequency of 66 Hz corresponds to inter-pulse intervals of ~15 ms; 
an interval which displayed a 30% reduction in Ca2+ release between first and second 
twitches at 30°C (Barclay, 2012). It would seem that as stimulus rate increases, Ca2+ is 
released more often; however, less Ca2+ is released in response to each pulse. This 
relationship reduces the amount of energy needed to cycle Ca2+, while cooperativity 
maintains a high level of thin filament activation.  
In fast twitch fibres, two Ca2+ ions are required to fully occupy TnC, whereas only 
one Ca2+ ion per TnC is required in slow twitch fibres. Additionally, within the fast 
twitch EDL, Ca2+ binding to TnC at its maximum was 75%, compared to 84% in the slow 
twitch soleus. The difference in TnC occupancy reflects the competition for Ca2+ between 
Tn and parvalbumin (PV) in fast muscle, which is absent in slow muscle (Barclay, 2012). 
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Ultimately, we see higher cooperativity in slow twitch muscles such as the soleus, 
because half as much Ca2+ is required to occupy all available binding sites on the slow 
TnC isoform, and there is no competition between Tn and PV. The more complex TnC 
regulatory mechanism in fast muscle, combined with the presence of PV, gives the 
advantage of accelerated relaxation (Gillis, 1985); however, this comes at the expense of 
the additional energetic overhead associated with removing the extra  Ca2+ from the 
myoplasm. Further energetic considerations of muscle activation, contraction, and 
relaxation will be discussed in sections to follow. 
2.3. Crossbridge Cycling 
The primary role of the intricately regulated interaction of actin and myosin is the 
generation of force and/or mechanical work (Winkelmann et al., 1991); this chief 
objective is accomplished as a consequence of the molecular dance known as crossbridge 
cycling (Krans, 2010). The term crossbridge stems from electron micrograph studies of 
skeletal muscle in rigor that revealed connections between the overlapping filaments, 
formed by the attachment of the globular head of myosin molecules to filamentous actin; 
these crossbridges are each independent force-generators (Rayment, Rypniewski, et al., 
1993b). Cyclical interaction of the motor domain of myosin with the actin filaments is 
driven by the concomitant hydrolysis of ATP by myosin ATPases (Rayment, Holden, et 
al., 1993a): The binding and subsequent hydrolysis of ATP triggers a sequence of 
conformational changes in the myosin S1 that are associated with an approximately 
10,000-fold change in its affinity for actin. The successive release of the hydrolysis 
products, Pi and ADP, causes large conformational changes that move myosin along actin 
filament (Behrmann et al., 2012).  
In the early 1970’s, the Lymn-Taylor Four State Cycle (Lymn & Taylor, 1971) 
was developed: A simplified framework used to comprehend the complex 
mechanochemical reaction cycle apparent during the cyclic interaction between actin and 
myosin. 
2.3.1. Lymn-Taylor Four State Cycle 
The four states of the cycle are Rigor, Post-Rigor, Pre-Power-Stroke, and Start-of-
Power-Stroke (Figure IV). In the absence of ATP the myosin head remains bound to F-
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actin in the Rigor complex. In Rigor, the cleft in the myosin head is closed, while the 
lever arm of myosin is in the down position. Upon binding of ATP, the large actin-
binding cleft in the myosin head opens by rotational movements of the upper (U50K) and 
lower 50K (L50K) domains, disrupting the actin-binding site, causing the myosin head to 
rapidly dissociate from F-actin. With the crossbridge now detached and in the Post-Rigor 
State, there is an isomerization causing a recovery stroke, bringing the myosin head to a 
catalytically competent Pre-Power-Stroke state through a movement of the lever arm 
from the down position to the up position, accompanied by a half closing of the actin-
binding cleft (Preller & Holmes, 2013). There is a rapid hydrolysis of ATP to form ADP 
and Pi on the free myosin head. The myosin-product complex is a meta-stable state with a 
long half-life which can await the arrival of an actin unit in the proper orientation to 
allow interaction (Lymn & Taylor, 1971). Now carrying the products of hydrolysis, the 
myosin head rebinds to the actin filament, followed by closing of the actin-binding cleft, 
and the crossbridge populates the Start-of-Power-Stroke State. Binding induces a 
conformational change, allowing the lever arm to swing from the up to the down position 
(Lymn & Taylor, 1971). After formation of the actin-myosin-product complex, 
dissociation of the products leaves the crossbridge in a configuration similar to that of a 
stretched spring, so tension is exerted or movement is produced in returning to the 
original conformation. This movement is called the Power Stroke, and facilitates sliding 
of actin past myosin. During the Power Stroke, Pi is released from the myosin head.  
Small conformational changes in the myosin head domains or crossbridges are 
amplified to large-scale motions and translocation of the bound actin filaments. The large 
cleft separating the myosin head between the U50K and L50K domains, along with the 
neck region, acts as a lever arm and conveys together with the adjacent converter domain 
local conformational changes to large scale movements (Preller & Holmes, 2013). These 
conformational changes bring the steps full circle, and the crossbridge is now in once 
again in the Rigor state. Rapid rebinding of ATP leads to myosin dissociation from the 
filament and initiates a new cycle (Behrmann et al., 2012). These microscopic 
movements are amplified by the sarcomere arrangement, and result in macroscopic force 
production and muscle shortening (Barclay, Woledge, & Curtin, 2010a). 
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Figure IV. The Lymn-Taylor four state crossbridge cycle. 
 
2.3.2. Kinetic Cycle  
The Lymn-Taylor 4 Stage Cycle is a grossly oversimplified explanation of the 
crossbridge cycle, but is helpful to understand actin-myosin interaction in a general sense. 
In reality, the 4 major stages, and their associated transitions, can be broken down further 
to explore the sequence of events involved in the myosin ATPase reaction sequence. The 
following is a brief synopsis of the kinetic cycle, expanded to include weakly bound and 
strongly bound states (Figure V): 
While sitting in rigor, the next kinetic cycle begins ATP rapidly binds to the 
myosin head which is currently associated with the actin filament, forming an actin-
myosin-ATP complex (AM ∙ ATP ), followed by the prompt dissociation of A  from M ∙ ATP. Next, a fast and reversible cleavage of ATP on the myosin head forms M ∙ ADP ∙ P!. The earlier rate of dissociation of the AM ∙ ATP complex to A and M ∙ ATP 
is so rapid and complete that virtually all cleavage of the nucleotide is completed on the 
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dissociated myosin head. Rapid reassociation of A and M ∙ ADP ∙ P! forms a weakly bound A−M ∙ ADP ∙ P! state that isomerizes to a more strongly bound AM.ADP.P! state - this 
transition is presumed to be regulated by Ca2+. Strongly bound AM ∙ ADP ∙ P! isomerizes 
to produce force and lever arm motion, i.e. the Power Stroke (AM ∗∗ ADP ∙ P!), and may 
be stabilized in the strong binding force-exerting form by the release of Pi. The transition 
from weakly bound A−M ∙ ADP ∙ P!  to AM ∗∗ ADP  involves a large change in free 
energy and is the transition during which force is generated. Isomerization is followed by 
rapid release of ADP (Gordon et al., 2000). 
 
Figure V. Mechanochemical reaction cycle between actin and myosin. 
  
   17 
2.4. Myosin Regulatory Light Chain Phosphorylation 
The myosin II molecule contains two light chains, the regulatory light chain 
(RLC) and essential light chain (ELC), non-covalently bound to the α-helix of the MHC 
lever arm, functioning to both stabilize it and form a regulatory domain (Alamo et al., 
2008). The myosin RLC has been known by several other names including light chain 2 
(LC2), and perhaps most relevant to the current discussion, the phosphorylatable light 
chain (P-light chain). Phosphorylation of skeletal muscle myosin RLC was first noted in 
the early 1970s during electrophoretic analyses of rabbit skeletal muscle myosin (Perrie, 
Smillie, & Perry, 1973). In smooth muscle, RLC phosphorylation is recognized as the 
primary mechanism for initiating contraction (Ding et al., 2009); however, determining 
its role in skeletal muscle has required more rigorous examination. 
2.4.1. Myosin Light Chain Kinase 
Skeletal myosin light chain kinase (skMLCK) first emerged in the literature when 
Pires and colleagues (Pires, Perry, & Thomas, 1974) discovered that the enzyme 
responsible for phosphorylating the myosin RLC differed in several properties from the 
enzymes assumed to play this role, such as phosphorylase kinase. They noted that 
skMLCK was similar to the Tn-Tm regulatory system in its Ca2+-sensitivity, and must 
therefore be fully active during the contractile cycle when myosin ATPase activity is high 
(Pires et al., 1974). In fact, the [Ca2+]i required to regulate myosin ATPase activity 
through thin filament activation is sufficient to activate skMLCK; thus, it seemed that this 
new enzyme, and RLC phosphorylation, may play a role in the regulation of skeletal 
muscle contraction (Klug, Botterman, & Stull, 1982). 
Only ~10% of RLCs are typically phosphorylated in resting skeletal muscle, as 
the activity of skMLCK is minimal in quiescent muscle. RLC phosphate content can be 
increased up to 7-fold when muscle is subjected to short duration (1-2 s) tetanic electrical 
stimulation or longer duration (5-20 s) low frequency (5-15 Hz) electrical stimulation 
(Manning & Stull, 1982). SkMLCK catalyzes phosphorylation of the phosphorylatable 
serine-15 residue within the N-terminus of myosin RLC, and as alluded to, is dependent 
upon Ca2+ and calmodulin (CaM) (Blumenthal & Stull, 1980). Activation of skMLCK is 
a two-step process (Figure VI) in which four Ca2+ ions bind to CaM forming a Ca2+4-
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CaM complex that subsequently binds to the inactive form of skMLCK, creating a 
catalytically active holoenzyme capable of phosphotransferase activity (Blumenthal & 
Stull, 1980). In the absence of Ca2+, as during rest, the kinase activity is auto-inhibited 
and CaM is not bound (Stull et al., 2011). The rate of CaM dissociation from skMLCK is 
slow, facilitating a longer period of skMLCK activity, even after [Ca2+]i has diminished 
to levels allowing relaxation to occur; thus, RLC phosphorylation is able to continue for a 
brief period of time after relaxation. This slow rate of skMLCK inactivation has been 
referred to as a biochemical memory that enhances RLC phosphorylation after skeletal 
muscles fibers have relaxed (Stull et al., 2011). 
 
Figure VI. Sequential activation of skMLCK and covalent modification of the myosin RLC. 
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2.4.2. Myosin Light Chain Phosphatase 
Since RLC phosphorylation is a form of covalent modulation catalyzed by 
skMLCK, there must exist another enzyme responsible for the reverse reaction, allowing 
the effect to remain transient. Indeed, it was soon discovered that the myosin RLC is 
dephosphorylated by a unique enzyme, highly specific for the RLC of myosin: Myosin 
light chain phosphatase (MLCP) (Morgan, Perry, & Ottaway, 1976). MLCP is composed 
of three distinct subunits including an isoform of protein phosphatase 1 (PP1cδ), a 
myosin-binding regulatory subunit isoform specific to striated skeletal muscle (MYPT2), 
and a small subunit whose function remains unknown (Matsumura & Hartshorne, 2008). 
In fast-twitch skeletal muscle, the maximal rate of RLC phosphorylation by skMLCK is 
~50-times faster than the rate of dephosphorylation by MLCP (Stull et al., 2011). The 
existence of highly specific enzymes for phosphorylation and dephosphorylation of a 
single serine residue on the RLC of all vertebrate muscle myosin naturally raises the 
question of purpose. Researchers have taken to mechanistic studies in an attempt to 
discover the physiological function of RLC phosphorylation. 
2.4.3. RLC Phosphorylation-Mediated Force Potentiation 
Phosphorylation of the myosin RLC has a direct and predictable influence on the 
contractile performance of fast twitch skeletal muscle. A large body of research, spanning 
nearly a century, has demonstrated an irrefutable temporal correlation between RLC 
phosphorylation and potentiation of isometric twitch force (for a review, see 
Vandenboom et al., 2013). Potentiation is readily induced in fast twitch skeletal muscles, 
and this phenomenon is now considered a fundamental property of fast twitch skeletal 
muscle; some researchers even believe it may even be a normal operating feature of these 
muscles (Brown & Loeb, 1998).  
Force potentiation is generally defined as an increase in isometric twitch force 
(Pt), independent of change to peak tetanic force (Po), increasing the twitch to tetanus 
ratio (Pt:Po) by heightening the Ca2+-sensitivity of the contractile apparatus (Vandenboom 
et al., 2013). Since RLC phosphorylation is a biochemical memory of previous contractile 
activity, and depends on the activation of skMLCK by Ca2+ and CaM, the precise 
manifestation of potentiation is variable and depends greatly upon the stimulation 
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paradigm. Potentiation displayed after a fused tetanus is referred to as post-tetanic 
potentiation (PTP), while potentiation seen after low frequency, repetitive stimulation is 
referred to as staircase potentiation (Grange, Vandenboom, & Houston, 1993; Manning & 
Stull, 1982). In stark contrast to fast twitch muscle, slow twitch muscle demonstrates a 
post-tetanic depression of isometric twitch force (Buller, Kean, Ranatunga, & Smith, 
1981). 
Some of the most persuasive work, shifting the correlative nature of RLC-
phosphorylation and force potentiation to a causal relationship, has come from studies 
using mice devoid of skMLCK (skMLCK-/-). This unique model was created from the 
ablation of the MYLK2 gene, rendering the skMLCK-/- mice unable to express skMLCK 
(Zhi et al., 2005). Mice devoid of skMLCK do not display isometric PTP like their 
Wildtype counterparts; although, an attenuated staircase effect remains in response to 
low-frequency repetitive stimulation (Zhi et al., 2005). This discovery was somewhat 
unexpected, and had resounding implications for the field of study, as it is now believed 
that a secondary potentiation mechanism may exist. 
2.4.4. Physiological Function of RLC Phosphorylation 
Initial investigations attempting to discover a functional role of RLC 
phosphorylation in skeletal muscle relied on measurements of ATPase activity; however, 
RLC phosphorylation has no effect on maximal myosin ATPase rate (Sweeney, Bowman, 
& Stull, 1993). The effect of RLC phosphorylation is related to head-rod interactions, by 
which force is potentiated by moving the myosin head closer to the thin filament. In the 
relaxed state, i.e. in the presence of ATP and absence of Ca2+, myosin heads exist in an 
ordered, helical array. Contrariwise, potentiation is associated with a disordering of active 
crossbridges (Duggal et al., 2014). The addition of a negatively charged phosphate 
moiety to the RLC results in charge repulsion between RLC and the thick filament 
backbone, disordering myosin heads positioned on the thick filament. This 
phosphorylation-induced loss of helical ordering is accompanied by a mass movement of 
myosin heads of about 6 nm away from the backbone surface (Figure VII), causing axial 
displacement of the heads out of the off-state towards the thin filament, resulting in 
modulation of Ca2+-Tn-dependent force generation (Stull et al., 2011). Moving heads 
closer to actin increases the likelihood of interaction, which in turn increases the force 
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produced and rate of force development. This was supported through the observations 
made by Yang et al. (1998), that decreasing the distance between thick and thin filaments, 
effectively decreasing the lattice spacing and thus increasing the proximity of myosin and 
actin, potentiated force similar to the potentiation from RLC phosphorylation at greater 
spacing. RLC phosphorylation does not seem obligatory for contraction, and does not 
regulate, but rather modulates interaction with actin, by potentiating force at submaximal 
Ca2+ levels (Sweeney et al., 1993).  
 
 
Figure VII. Mass movement of myosin heads away from thick filament backbone upon RLC 
phosphorylation. 
 
RLC phosphorylation is also suspected to stiffen, and increase stability of the 
lever arm of myosin (Rayment, Holden, et al., 1993a). The neck region has been cited as 
a major source of crossbridge compliance; hence, a phosphorylation-induced stiffening of 
the lever arm would more efficiently transmit conformational changes into force, and 
could possibly increase unitary step size (Greenberg et al., 2009). The neck region also 
serves as a molecular strain sensor; thus, changing the stiffness of the lever arm would 
also change the strain sensitivity of the myosin biochemistry. The increased sensitivity to 
load would theoretically slow the rate of strain-dependent ADP release from the 
nucleotide pocket, increasing the myosin duty cycle (i.e. the fraction of time myosin 
spends bound to actin). Indeed, through use of an in vitro motility assay of endogenously 
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phosphorylated myosin, Greenberg et al. (2009) demonstrated a 44% increase in myosin 
duty cycle, accompanied by a 20% reduction in unloaded shortening velocity due to 
phosphorylation-based changes in myosin motor function. Overall, the in vitro motility 
assay demonstrated a reduced sliding velocity and an increased myosin duty cycle, 
resulting from phosphorylation-induced stiffening of the myosin lever arm. 
2.4.5. Brenner Two-State Model 
The simplified framework used to explain the physiological utility of myosin 
RLC phosphorylation was originally introduced by Brenner (1988), and extended the 
original crossbridge model of contraction  (Huxley, 1957). This useful tool reduces the 
multiple states of the aforementioned crossbridge kinetic cycle to a simplistic two-state 
model. This model employs the apparent rate constants 𝑓!"" and 𝑔!"", describing the 
transition from non-force generating to force generating states, and the transition from 
force-generating to non-force generating states, respectively (Sweeney & Stull, 1990).  
RLC phosphorylation is believed to affect 𝑓!"", with no effect on 𝑔!"", or the 
number of cycling crossbridges. Therefore, the increase in force production seen at low 
levels of Ca2+ activation is not due to recruitment of more crossbridges into cycling per 
se, but rather due to an increase in the already cycling crossbridges that are strongly 
bound to actin and contributing to force production (i.e.  𝑓!""). This framework can also 
explain why increased force production is observed at submaximal [Ca2+]i, while 
increased rate of force development is observed at maximal [Ca2+]i, concomitant with 
RLC phosphorylation.  
2.4.5.1. Force Production 
Equation I describes the steady-state fraction of cycling crossbridges in the force-
generating state (𝛼!") as a function of the rate constants 𝑓!"" and 𝑔!"". In theory, the 
number of cycling crossbridges (𝑛) and unitary force per crossbridge (𝐹) remain constant 
during RLC phosphorylation, while the fraction of crossbridges transitioning to the force-
generating state (𝑓!"") increases. During submaximal stimulation, [Ca2+]i is low, the 
contractile apparatus is not yet fully activated, and 𝑔!"" is theoretically greater than 𝑓!"". 
According to Equation I, during this time, a small increase in 𝑓!"" will result in a large 
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change in the fraction of cycling crossbridges in the force-generating state, causing a 
large change in isometric force (as a function of number of crossbridges, unitary force, 
and the fraction of crossbridges contributing to force development, shown in Equation II).  
 𝜶𝑭𝒔 = 𝒇𝒂𝒑𝒑/(𝒇𝒂𝒑𝒑 + 𝒈𝒂𝒑𝒑) 
Equation I. Fraction of crossbridges in the force-generating state. 
 𝐹 = 𝑛𝐹𝛼!"   
Equation II. Isometric force equation. 
 
Consequently, as 𝑓!"" becomes increasingly larger relative to 𝑔!"", as expected 
during high levels of Ca2+ activation, any further increases in 𝑓!"" resulting from RLC 
phosphorylation will have proportionally less effect on force. 
 
When 𝑪𝒂𝟐! 𝒊  is low 𝒈𝒂𝒑𝒑 ≫ 𝒇𝒂𝒑𝒑 
 ↑ 𝜶𝑭𝒔 =↑ 𝒇𝒂𝒑𝒑/(↑ 𝒇𝒂𝒑𝒑 +𝒈𝒂𝒑𝒑) 
 
 
When 𝑪𝒂𝟐! 𝒊  is high 𝒈𝒂𝒑𝒑 ≪ 𝒇𝒂𝒑𝒑 
 ↔ 𝜶𝑭𝒔 =↑ 𝒇𝒂𝒑𝒑/(↑ 𝒇𝒂𝒑𝒑 + 𝒈𝒂𝒑𝒑) 
 
The myosin duty cycle, i.e. the time myosin is spent bound to actin, increases in 
the phosphorylated state because an increase in 𝑓!"" with no change in 𝑔!"" will lead to 
crossbridges that tends to populate the strongly bound state. While this will increase the 
force production, a higher duty ratio leads to decreased shortening velocity, as some 
crossbridges inevitably exert a braking effect on the sliding filament.  
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2.4.5.2. Rate of Force Redevelopment 
The rate of isometric force redevelopment, represented in Equation III by the term 𝐾!"#"$, is equivalent to the sum of 𝑓!"" and 𝑔!"". Therefore, in situations of low Ca2+ 
activation when 𝑓!"" is smaller than 𝑔!"", a large fractional increase in 𝑓!"" has little 
effect on 𝐾!"#"$, which theoretically approaches 𝑔!"" at low [Ca2+]. However, at higher 
Ca2+ activation, when 𝑓!"" is larger than 𝑔!"", even a small fractional increase in 𝑓!"" 
results in significant increase in 𝐾!"#"$; thus, the greatest effect of RLC phosphorylation 
on 𝐾!"#"$ is observed at [Ca2+] greater than where effects on force are observed.  
 𝐾!"#"$ =   𝑓!"" + 𝑔!""   
Equation III. Rate of force redevelopment equation. 
 if      𝑓!"" ≪ 𝒈𝒂𝒑𝒑      then      𝐾!"#"$ ≈ 𝑔!"" 
 ↔ 𝐾!"#"$ =  ↑ 𝑓!"" +𝒈𝒂𝒑𝒑 
 
 if      𝒇𝒂𝒑𝒑 ≫ 𝑔!""      then 
 ↑ 𝐾!"#"$ =  ↑ 𝒇𝒂𝒑𝒑 + 𝑔!"" 
 
2.4.5.3. Myosin ATPase Rates 
The steady-state isometric myosin ATPase rates (𝑟!) can be expressed as the 
product of the number of cycling crossbridges (𝑛), the number of half sarcomeres in the 
fibre (𝑏), 𝑔!"" , and the fraction of crossbridges in the force-producing state (𝛼!" ) 
(Equation IV). Myosin ATPase activity has been shown to be proportional to force 
(Potma, Stienen, & Barends, 1994), and the relationship between isometric force (𝐹) and 𝑟! were determined experimentally to be linear (Brenner, 1988), validating the variable 
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terms in Equation II and Equation IV. Accordingly, RLC phosphorylation-mediated 
increases in 𝑓!"" increase 𝛼!", resulting in a proportional increase in both 𝐹 and 𝑟!. 
 𝑟! = 𝑛𝑏𝑔!""𝛼!" 
Equation IV. Isometric myosin ATPase rates. 
 
2.4.6. Why Phosphorylate the RLC? 
Although a plethora of mechanistic research has proven that RLC phosphorylation 
benefits the contractile performance fast twitch skeletal muscles in vitro, Vandenboom et 
al. (2013) point out that a conclusive teleological role in vivo has not yet been identified. 
While some researchers believe that the potentiated state is the normal working state of 
fast twitch muscle (Brown & Loeb, 1998), others have suggested that phosphorylation of 
skeletal muscle RLC is only a residual trace of the evolution of cardiac myosin (Duggal 
et al., 2014). It may be that the mechanical changes observed during in vitro studies are 
nothing but an inevitable consequence incorporating a negative charge to the lever arm of 
myosin. In an evolutionary perspective, the eradication of an enzyme is only conceivable 
if its function can be dispensed with (Atkinson, 1977); thus, it stands to reason that the 
existence of highly specific enzymes responsible for the phosphorylation-
dephosphorylation cycle of a single serine residue on the RLC of all skeletal muscle 
myosin signifies that RLC phosphorylation remains important to the performance of 
skeletal muscle. 
Actin and myosin interact in skeletal muscle regardless of whether or not myosin 
is phosphorylated. Perhaps skMLCK plays yet another role that has yet to be elucidated, 
validating its very existence. An in vitro motility assay revealed that inactive skMLCK 
binds to actin, and inhibits actin-myosin interaction (Fujita et al., 1999). Interestingly, 
this inhibitory effect is overcome in a Ca2+-dependent manner, such that the presence of 
Ca2+4-CaM, and the sequential activation of skMLCK, affects its actin-binding activity 
(Fujita et al., 1999). It seems possible that the actin-binding activity of skMLCK may be 
another level of regulation of thin-filament activation controlling actin-myosin 
interaction. If these findings are substantiated, it would have resounding implications on 
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the regulatory mechanism of contraction. The prospective story of the regulation of 
contraction may be the following: 
During the initiation of contraction, Ca2+-occupancy of TnC removes 
steric blocking of actin-myosin interaction by Tm. Simultaneously, Ca2+4-
CaM complexes with skMLCK removing it from the actin filament, further 
disinhibiting the actin-myosin interaction. Ca2+4-CaM-skMLCK then 
phosphorylates the RLC, disorganizing the array of myosin heads, 
projecting them off the thick filament backbone, and increasing the 
likelihood of actin-myosin interaction and cooperativity, augmenting the 
Ca2+-sensitivity of the contractile apparatus. All while RLC phosphorylation 
stabilizes the lever arm, improving the transmission of conformational 
changes into force.    
   27 
2.5. Metabolic Considerations of Mammalian Skeletal Muscles 
Adenosine triphosphate (ATP) is the best-known, and most widespread example 
of a common intermediate whose role is to carry chemical energy. ATP is colloquially 
referred to as the energy currency of the cell, and as such, is the immediate energy source 
for biological processes in skeletal muscle. Enzymes harness the energy released from the 
hydrolysis of ATP to perform useful work (Equation V).  
 𝐴𝑇𝑃 + 𝐻!𝑂 → 𝐴𝐷𝑃 + 𝑃! + 𝐸𝑛𝑒𝑟𝑔𝑦 
Equation V. Hydrolysis of adenosine triphosphate. 
 
During contractile activity, three principle enzymatic reactions hydrolyze ATP, 
constituting the majority of the ATP consumption within active skeletal muscle.  
2.5.1. Energetics of Skeletal Muscle Contraction  
The major ATP-consumers of skeletal muscle contraction include the following: 
The Sodium-Potassium ATPase (Na+-K+ ATPase), responsible for maintaining the 
electrochemical gradient, and thus the excitability of the sarcolemma; the myosin 
ATPase, responsible for powering the crossbridge cycle; and the Sarco-Endoplasmic 
Reticulum Calcium ATPase (SERCA), responsible for clearing Ca2+ from the myoplasm 
by sequestering it within the SR lumen (MacIntosh, Gardiner, & McComas, 2006; Rolfe 
& Brown, 1997; Tiidus, Tupling, & Houston, 2012). These 3 reactions (Figure VIII) 
dictate that force generation and trans-membrane ion pumping account for the vast 
majority of energy expended by contracting skeletal muscles, and that skeletal muscles 
require energy to both generate force and terminate contraction, via myosin ATPase and 
SERCA respectively (MacIntosh et al., 2012). During rest it is accepted that the Na+-K+ 
ATPases accounts for 19-28% of ATP consumption, while SERCA and myosin ATPases 
account for 4-8% and 2-8%, respectively (Rolfe & Brown, 1997) - the remainder being 
utilized for anabolic processes and cellular regeneration. However, during muscular 
contraction the relative contribution to ATP consumption shifts drastically.  
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Figure VIII. Major energy consuming processes during skeletal muscle contraction. 
2.5.2. Activation Energy Turnover  
Since the majority of energy consumed by muscle contraction can be accounted 
for by two sets of ATP-dependent, cyclical processes (crossbridge cycling and Ca2+ 
cycling), it is commonplace for research investigating energy use by skeletal muscle to 
partition energy consumption into contractile and non-contractile ATP consumption. 
Energy turnover for ion pumping (i.e. Na+-K+ ATPase and SERCA), is referred to as the 
activation energy turnover (EA) – and simply put, is all energy unrelated to crossbridge 
cycling (Barclay, Lichtwark, & Curtin, 2008; Barclay, Woledge, & Curtin, 2007). Energy 
partitioning is accomplished during in vitro studies through either pre-stretching the 
muscle to long sarcomere lengths to inhibit crossbridge cycling (Homsher, Mommaerts, 
Ricchiuti, & Wallner, 1972) or selective inhibition of crossbridge cycling through 
pharmacological agents such as 2,3-butanedione monoxime (BDM) or N-benzyl-p-
toluene sulphonamide (BTS) (Barclay et al., 2008). BTS is currently the preferred 
pharmacological agent used to reversibly suppress force production of fast skeletal 
muscle due to its high specificity, and minimal interaction with Ca2+ metabolism (Cheung 
et al., 2001). The energy turnover in intact fibres is measured through either enthalpy 
production (e.g. Barclay, Constable, & Gibbs, 1993), biochemical analysis of metabolites 
(e.g. Homsher et al., 1972), or nuclear magnetic resonance (e. g. Baker, Brandes, & 
Schendel, 1994). 
Historically, researchers believed that 50-80% of the total ATP consumed during 
skeletal muscle contraction was attributed to the myosin ATPase, with the remainder 
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accounted for by ion pumping (Zhang, Andersson, Sandstrom, Westerblad, & Katz, 
2006). Yet, during continuous isometric tetanic contractions in which myosin ATPases 
had been inhibited via BTS, ATP turnover was reduced by only 20% (Zhang et al., 2006). 
This evidence suggested that ion pumping, and not crossbridge cycling, is the major user 
of energy during contraction in fast twitch skeletal muscle under near-physiological 
conditions. While these findings seemed groundbreaking at first glace, a letter to the 
editor by Barclay & Loiselle (2007) criticized Zhang’s interpretation of data. Several of 
Barclay’s subsequent papers called into question the methods used by Zhang et al. 
(2006), including their unacceptably slow freezing technique that may have allowed ATP 
hydrolysis to continue for several seconds (Barclay et al., 2007; 2008). In a response to 
the findings from Zhang et al. (2006), Barclay et al. (2008) determined that EA accounts 
for just over 1/3 of energy turnover during isometric contractions in mouse EDL. These 
EA values were the same regardless of the energy partitioning methods (i.e. reduced 
filament overlap or BTS).  
EA has been measured among muscles from different species (e.g. mouse, rat, fish, 
frog, human), all with different contractile and energetic properties. Regardless of these 
inherent differences, the experimental EA value is often near 30% (Barclay et al., 2007; 
2008). Lou, Curtin, and Woledge (1997) suggested that this 30% EA is not simply an 
arbitrary value, and put forth the Energy Minimization Hypothesis. On one hand, slower 
SR Ca2+ reuptake would reduce EA, but at the expense of slower relaxation leading to an 
extended crossbridge cycling cost. On the other hand, faster Ca2+ reuptake would hasten 
relaxation, halting energy consumption by crossbridge cycling, but at the expense of 
increased SERCA ATP consumption. It would seem that skeletal muscle, across many 
species, has evolved with a common goal of efficiency in mind. 
An overlooked process that consumes ATP, and a potential contributor to EA of 
fast twitch skeletal muscle, is phosphorylation of the myosin RLC. Although very little 
research has been done to investigate the energy turnover required to phosphorylate the 
RLC, it is likely that it is not a trivial amount. Following a fused tetanus, over 50% of the 
RLCs are phosphorylated (Vandenboom et al., 2013). It follows that if there are 125,822 
crossbridges per µm3, equating to a whole muscle concentration of 0.21 mM (Barclay, 
Woledge, & Curtin, 2010a), each with an RLC, then 1 cubic centimeter of muscle would 
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contain 0.21 µmol of RLCs. Phosphorylating 50% of the RLCs a single time would 
require the hydrolysis of 0.105 µmol of ATP (Equation VI); however, this is simply an 
instantaneous value, and the phosphorylation-dephosphorylation cycle that occurs in vivo 
during contraction would inevitably consume more ATP. Homsher (1987) predicted that 
the quantity of ATP consumed for this process may be equivalent to 5% of the energy 
used during a 5 s tetanus, but no research was conducted in attempt to reach a definitive 
answer. 
 0.21  𝑚𝑚𝑜𝑙  𝑋𝐵𝑠𝐿 ∙ 1  𝐿1000  𝑐𝑚! ∙ 1000  𝜇𝑚𝑜𝑙1  𝑚𝑚𝑜𝑙 = 0.21  𝜇𝑚𝑜𝑙  𝑋𝐵𝑠 
 0.21  𝜇𝑚𝑜𝑙  𝑋𝐵𝑠   ∙ 50%  𝑜𝑓  𝑅𝐿𝐶𝑠 ∙ 1  𝐴𝑇𝑃1  𝑅𝐿𝐶 = 0.105  𝜇𝑚𝑜𝑙  𝐴𝑇𝑃 
Equation VI. ATP consumed during a single instantaneous phosphorylation of 50% of RLCs. 
 
2.5.3. Efficiency of Muscle Contraction 
Skeletal muscle is a thermodynamic machine, capable of directly transducing 
chemical energy into mechanical energy, and naturally, the transaction process occurs 
with some inherent degree of efficiency (Smith, Barclay, & Loiselle, 2005). Efficiency 
(Equation VII) is a quantification of the degree of conversion of chemical energy into 
work (Barclay, Woledge, & Curtin, 2010a), and can be defined in general terms as the 
ratio of mechanical power output (i.e. work completed) to metabolic power input (i.e. 
energy consumed) (Barclay, 1996).  
 𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 = 𝑊𝑜𝑟𝑘  𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒𝑑𝐸𝑛𝑒𝑟𝑔𝑦  𝑐𝑜𝑛𝑠𝑢𝑚𝑒𝑑 
Equation VII. General efficiency equation. 
 
The precise definition of efficiency used depends on the method employed, the 
variables investigated, and the metabolic processes encompassed by the term metabolic 
power input. Several common definitions will be explored.  
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First, when a muscle contracts and shortens against a load it performs work 
(Equation VIII), fuelled by the expenditure of metabolic energy. Enthalpy is a term that 
describes thermodynamic potential, or the internal energy of system, and change in 
enthalpy (∆𝐻) reflects the difference in energy that occurs during the performance of 
work. Enthalpy (Equation IX), denoted with a negative sign signifying a decrement of 
internal energy, includes the thermal accompaniment of work, and is equated to work (𝑤) 
plus heat (ℎ). Thus, the ratio of work performed to enthalpy produced provides a measure 
of mechanical efficiency (𝜀), as shown in Equation X. 
 𝑊 =   𝐹 ∙ 𝑑  
Equation VIII. Work defined as the product of force and displacement.    −∆𝐻 =𝑊 + ℎ 
Equation IX. Enthalpy change is useful work and its thermal accompaniment. 
 𝜀 = 𝑊∆𝐻 = 𝑊𝑊 + ℎ 
Equation X. Mechanical efficiency is the ratio of work to enthalpy. 
 
As discussed, the energy turnover for Ca2+ cycling constitutes a substantial faction 
of the cost of contraction in skeletal muscle. Although this energy is essential for 
contraction, it cannot be converted into mechanical work; thus, the efficiency of intact 
muscle will inevitably be less than that of the work generated by crossbridges alone 
(Barclay et al., 2007). If the primary interest is in the efficiency of the actin-myosin 
crossbridges, the metabolic overheads associated with basal metabolism and ECC (i.e. 
EA), together with those of subsequent metabolic recovery processes must be subtracted 
from the total heat and work observed (Smith et al., 2005). 
Based on first law of thermodynamics, the Law of Conservation of Energy, the 
enthalpy change from chemical breakdown in a muscle is converted into either heat or 
work. The heat liberated from a muscle during contraction stems from the same 
biochemical reactions that power the work it performs when lifting a load; thus, 
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measurements of the rates of heat and work output from a muscle (i.e. enthalpy) can 
provide an indirect measure of the rate of ATP breakdown. While the metabolic power 
source for contraction is ATP hydrolysis, this reaction is rapidly reversed at the expense 
of phosphocreatine (PCr) through the creatine kinase (CK) reaction, which will be 
discussed in depth in the upcoming sections. Under normal working conditions, there is 
no net breakdown of ATP as is it rapidly resynthesized by the CK reaction. For that 
reason, the net chemical change during contraction is the breakdown of PCr, and the 
enthalpy liberated from a contracting muscle proportional to the rate of PCr hydrolysis 
which is reflected in the heat and work production (Barclay et al., 1993). 
Although Equation X seems appealing for determining efficiency, it can be 
somewhat misleading as not all of the enthalpy change is actually available to perform 
useful work, and only a fraction of the heat produced during contraction can be explained 
by chemical changes (de Haan et al., 1986). Since the fraction available to perform work 
is termed the Gibbs free energy (∆𝐺), a more useful measurement in this area of study is 
thermodynamic efficiency (Equation XI): 
 𝜂 = 𝑊∆𝐺!"# 
Equation XI. Thermodynamic efficiency. 
Where: ∆𝐺!"# = ∆𝐺!"#° + 𝑅𝑇 ln 𝐴𝐷𝑃 [𝑃!][𝐴𝑇𝑃]  
Equation XII. Free energy released during ATP hydrolysis. 
 ∆𝐺!"# can be determined experimentally using Equation XII. Several terms 
remain constant, including  ∆𝐺!"#° , the standard Gibbs free energy associated with ATP 
hydrolysis and 𝑅, the gas constant. Thus, by measuring 𝑇, temperature of the active 
muscle, and the intracellular ADP:ATP ratio, one can calculate  ∆𝐺!"# and subsequently, 
thermodynamic efficiency. 
Enthalpy and free energy change are common indices of the energy consumed; 
however, it is also possible to measure changes in intracellular concentrations of ATP 
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and/or PCr, without the equipment necessary to measure heat production. The extent of 
chemical breakdown, referred to as high-energy phosphate consumption or HEPC (e.g. 
Abbate et al., 2001), can be measured by stopping the chemical reactions at a set time by 
rapid freezing and analyzing the chemical composition of the extracts. This technique 
uses intact fibres, giving an advantage over skinned fiber studies in that the crossbridges 
are functioning in their normal intracellular environment (Barclay, Woledge, & Curtin, 
2010a). The ratio of force or work produced to high-energy phosphate consumption is 
referred to as economy (Goldspink, 1978) to differentiate it from the classical 
thermodynamic definitions of efficiency. Economy (Equation XIII) can be expressed as 
Ns/µmol energy-rich phosphate (~P) (De Haan et al., 1986) or J/µmol ~P (Abbate et al., 
2001). 
 𝐸𝑐𝑜𝑛𝑜𝑚𝑦 =   𝐹  𝑜𝑟  𝑊𝐻𝐸𝑃𝐶  
Equation XIII. Economy calculated using consumption of high-energy phosphates. 
 
2.5.4. Possible Factors Impacting Efficiency and Economy 
2.5.4.1. Fibre Type 
It is well established that the mechanical and energetic properties of muscle fibres 
are determined to a large extent my myosin isoforms. MHC isoforms determine isometric 
ATP consumption, tension cost and rate of tension redevelopment after unloaded 
shortening. The efficiency of fast twitch mouse EDL is 0.29 – 0.33, while slow twitch 
mouse soleus is 0.33 to 0.43 (Barclay, 1996; Barclay et al., 1993). 
2.5.4.2. Temperature 
It would seem plausible that since temperature has a drastic effect on enzymatic 
activity and metabolism, that temperature would also be a major factor in the mechanical 
efficiency of a working muscle. Interestingly enough, it appears that the maximum 
mechanical efficiency of isolated mouse muscle is little affected by temperature between 
the range of 20 to 30°C (Barclay, Woledge, & Curtin, 2010b).  
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2.5.4.3. Contraction Type 
During isometric contractions, no shortening is performed; thus, no work is 
performed, making the previous efficiency calculations impossible. This hurdle is 
overcome by utilizing the area under the force-time curve, referred to as the force-time 
integral (FTI), which is commonly used to approximate isometric work (e.g. Chasiotis, 
Bergstrom, & Hultman, 1987; Crow & Kushmerick, 1982a; Hogan, Ingham, & Kurdak, 
1998; Russ, Elliott, Vandenborne, Walter, & Binder-Macleod, 2002). Interestingly, brief 
intermittent contractions produce greater ATP turnover compared to longer sustained 
contractions when either the total contraction time (Bergstrom & Hultman, 1988) or total 
number of contractions (Hogan et al., 1998) remains constant. This led to the hypothesis 
that force generation is more costly than force maintenance. To determine the answer in 
vivo using 31P-NMR spectroscopy, Russ et al. (2002) measured the metabolic cost and 
ATPase rates in human muscle (medial gastrocnemius) in response to various stimulation 
frequencies and durations. Their work confirmed the notion that in mammalian skeletal 
muscle, the metabolic cost of attaining isometric force is higher than maintaining that 
force output. ATPase rates during short contractions are higher than during long 
contractions, making the initial production of force more metabolically costly than 
maintaining it (Russ et al., 2002). 
Contradictory to early studies in which energy output was thought to decrease 
during shortening to a level below isometric energy consumption, follow up work 
suggested that energy consumption increases when external work is performed (Reggiani 
et al., 1997). This phenomenon was dubbed the Fenn Effect, which dictates that when a 
muscle shortens and does mechanical work, additional energy is liberated above that 
appearing in the isometric contraction, the additional energy liberated is proportional to 
the work done (i.e. the distance shortened or the load) (Fenn, 1923; 1924). The energy 
liberated by contraction is not dependent solely upon the initial mechanical and 
physiological condition of the muscle, but can be modified by the nature of the load, 
which the muscle discovers during stimulation. The driving reactions are regulated by the 
force and or shortening occurring in contraction (Woledge, Curtin, & Homsher, 1985). 
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2.5.4.4. Activation Level 
Level of activation, defined as the availability of crossbridge binding sites on the 
thin filament, is dependent upon [Ca2+]i and thus the stimulation paradigm. Abbate, de 
Ruiter, Offringa, and Sargeant (2002) determined efficiency was lower when using 
maximal activation (150 Hz) compared to submaximal activation at two different 
frequencies (60 or 90 Hz) during in situ isovelocity shortening contractions of rat 
gastrocnemius. It is likely that maximal activation by high frequency stimulation leads to 
a decreased efficiency, as the result a larger efflux of Ca2+, resulting in an increased 
energy expenditure by SERCA relative to total energy turnover. Another possible 
explanation is that the reduction in force at submaximal activation is accompanied by an 
alteration in the crossbridge efficiency.  
Lewis & Barclay (2014) picked up where Abbate et al. (2002) and several other 
groups left off, as no clear consensus was reached as to the effect of activation level on 
efficiency. It was confirmed that less Ca2+ is released at submaximal than maximal 
stimulation frequencies, lending weight to the theory that increased SERCA activity 
reduces efficiency at during maximal activation (Abbate et al., 2002). However, it 
appears that skeletal muscles are actually less efficient during low levels of activation 
because a lower [Ca2+]i leads to the performance of fewer crossbridge cycles, and more 
importantly, less work per crossbridge cycle (Lewis & Barclay, 2014). 
Overall, it seems that the efficiency and economy of a working muscle is 
dependent on a number of factors, including the muscle fibre type, the force required to 
move a load, the distance of shortening, and the level of activation, whereas temperature 
and species do not play an important role. 
2.5.5. Energy Producing Processes in Skeletal Muscle 
Energy balance must be attained for proper functioning of skeletal muscle tissue, 
meaning that ATP utilization must be met with an equal ATP production. This is true 
even during times of intense exercise, when energy demands increase 100-fold almost 
instantaneously. The ATP concentrations in skeletal muscle tissue are low, ranging from 
2 to 6 mmol of ATP per kilogram, which theoretically would only be sufficient to sustain 
up to two seconds of maximal work (Tiidus et al., 2012). 
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2.5.5.1. Adenylate Charge 
Energy transduction and energy storage involving ATP, ADP, and AMP, 
collectively referred to as the adenylates, are at the core of skeletal muscle metabolism. 
These adenine nucleotides interact with every energy consuming and producing reaction 
within the muscle, and directly impact enzymatic reactions through mass action and end-
product inhibition. Thus, uncontrolled changes in the relative concentrations of ATP, 
ADP and AMP would affect the rates of all metabolic reactions and be highly disruptive. 
Close control of the relative concentrations is essential to correlation of fluxes through 
metabolic pathways. Since ATP is consumed or regenerated in every metabolic sequence, 
the level of energy storage in the adenylate system can be controlled by governing the 
rates of all metabolic sequences, through sensing the energy level of the adenylate system 
and using this information as a basis of control (Atkinson, 1977). 
A useful concept is the Adenylate Energy Charge, which allows the energetic 
state of a biological system to be expressed quantitatively. It is a measure of the 
phosphorylating power of an adenylate pool, equal to one half the average number of 
anhydride-bound phosphoric groups per adenosine moiety present in the pool (A. D. 
Smith, 2000). Defined in terms of the concentrations of AMP, ADP and ATP in the pool, 
and expressed by the quotient in Equation XIV.  
 𝐴𝑇𝑃 + 0.5 𝐴𝐷𝑃𝐴𝑇𝑃 + 𝐴𝐷𝑃 + 𝐴𝑀𝑃  
Equation XIV. Adenylate energy charge. 
 
The adenine nucleotides within the cell are often described using the analogy of 
chemicals in a battery (Atkinson, 1977; Hardie & Hawley, 2001): The battery of the 
skeletal muscle cell is charged up by converting ADP and Pi to ATP, while the battery is 
discharged by cellular processes coupled to ATP breakdown. Theoretically, a completely 
charged battery would be reflected by an adenylate energy charge of 1 (all ATP), while 0 
(all AMP) would reflect a completely discharged battery. On average, the quantity of 
ATP used per second is equal to the steady-state amount of ATP in the cell, meaning that 
total ATP turnover time is typically of the order of 1 second or less (Atkinson, 1977). In 
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other words, the capacity of the adenylate battery is so small that it would be totally 
discharged in about a second if charging were to stop and energy use to continue at a 
normal rate. 
2.5.5.2. Maintenance of the ATP:ADP Ratio 
One of the most fundamental parameters that any healthy muscle cell must 
maintain is a high ratio of ATP to ADP, usually around 10:1. Healthy cells maintain the 
reactants and products of hydrolysis reactions many orders of magnitude away from their 
equilibrium ratios, ensuring that the energy from hydrolysis can be harnessed to perform 
useful work when coupled to processes requiring an input of energy (Hardie & Hawley, 
2001). ATP is highly conserved by efficient buffering by the CK reaction, and any 
decrease in ATP is small. However since muscle content of ADP is 10-fold lower than 
ATP, even a small decrease in ATP can drastically increase ADP. Increases in [ADP] 
will reduce the free energy released during ATP hydrolysis (∆𝐺!"#), and eventually 
impair all ATPase reactions, reducing the amount of useful work that can be performed. 
CKs important function is not only to defend ATP concentration but also prevent large 
increases in ADP. The concentration of ATP is maintained by three key energy systems, 
of which the two anaerobic systems will be discussed. The potential energy sources 
during muscular activity of short duration include partial depletion of the endogenous 
ATP store, breakdown of phosphocreatine (PCr), anaerobic glycolysis to lactate, and 
oxidative metabolism (Spriet, 1989).  
The contribution of the endogenous ATP store is quantitatively insignificant in 
most contractile situations, as it is highly conserved, and oxidative metabolism 
contributes in only a minor way during intense exercise of short duration; thus, the major 
sources of ATP resynthesis during intense anaerobic muscular activity are PCr 
degradation, and glycolysis from glycogen (Spriet, 1989). The net production of ATP 
from these two anaerobic systems is known as substrate-level phosphorylation, and 
includes the following enzyme catalyzed reactions: the creatine kinase reaction, the 
adenylate kinase and AMP deaminase reactions, the glycolytic pathway reactions, and the 
lactate dehydrogenase reaction.   
   38 
2.5.5.3. Creatine Kinase Reaction  
A major problem facing skeletal muscle fibres is the large disparity between 
energy demand at rest, and the energy demands of contraction, as they differ by more 
than an order of magnitude (Sweeney, 1994). The creatine kinase (CK) reaction 
(Equation XV), also referred to as the Lohmann reaction, is very effective at maintaining 
the ATP concentration during muscular activity (Woledge et al., 1985). At the onset of 
contraction, the increased ATP demand is immediately met by a shift in the CK reaction 
that decreases [PCr] without a change in [ATP]. The reaction has an equilibrium constant 
of 100 at physiological pH and temperature; meaning that this near equilibrium dead-end 
reaction is pushed towards products, and the equilibrium shift keeps [ATP] relatively 
constant over a wide range of ATP fluxes in the cell (Woledge et al., 1985). 
Consequently, a reduction in the PCr:Cr ratio results in a much smaller reduction in the 
ATP:ADP ratio. PCr acts as an energy buffer by providing an additional pool of energy 
rich phosphate compounds (i.e. an energy reserve) to aid in maintaining cellular ATP 
levels. This reservoir of high-energy phosphates defends cellular ATP levels under 
anaerobic conditions, high rates of energy transfer, or rapid fluctuations in energy 
requirements (Sahlin & Harris, 2011).  
 𝑃𝐶𝑟 + 𝐴𝐷𝑃 + 𝐻!                        !"#$%&'#  !"#$%&                     𝐴𝑇𝑃 + 𝐶𝑟 
Equation XV. Regeneration of ATP through the creatine kinase reaction. 
 
To be considered a biochemical capacitor, the flux capacity of a buffer reaction 
must be greater than the flux of the reaction being buffered; indeed, the flux of CK is 
much higher than either maximal ATPase or ATP synthesis flux. PCr is a sensitive 
indicator of the energetic status of the cell because changes in ATP flux cause a shift in 
the CK equilibrium that is reflected in [PCr]. The CK reaction has well-established roles 
as a temporal and spatial buffer of ATP, a proton buffer, and a key controller of oxidative 
phosphorylation (Sahlin & Harris, 2011). Temporal buffering, or metabolic capacitance, 
allows for a lower mitochondrial density than would be necessary to support the peak 
energy demand during contraction. The metabolic capacitance offered by the CK reaction 
lowers the apparent peak demand and increases the period of elevated energy demand so 
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that much of the regeneration of ATP is distributed to the resting state. The CK reaction 
is a more economical energy delivery system used by cells that have a peak energy 
demand that is in excess of its average energy demand (Sweeney, 1994) such as fast 
twitch skeletal muscle. The CK reaction generates ADP, the key factor in regulating 
mitochondrial oxidative phosphorylation, and thus oxidative ATP supply. In essence, 
there is a double role of the shift in PCr, not only buffering short-term ATP demands, but 
also elevating the signal for longer-term oxidative ATP supply. 
2.5.5.4. Adenylate Kinase and AMP Deaminase Reactions 
During intense muscular activity, the rate of ATP hydrolysis increases 
instantaneously. Although ATP is being resynthesized from ADP and PCr through the 
CK reaction, there is an inevitable rise in [ADP]. Large increases in [ADP] activate the 
adenylate kinase (AK), or myokinase reaction (Equation XVI), which transfers the Pi 
from one ADP to another, regenerating one molecule of ATP while creating AMP, or 
adenosine monophosphate (Sahlin & Harris, 2011).  
 2  𝐴𝐷𝑃                 !"#$%&'(#  !"#$%&                     𝐴𝑇𝑃 + 𝐴𝑀𝑃 
Equation XVI. Adenylate kinase reaction. 
 
The rate constant of the AK reaction is unitary under normal resting conditions, 
implying that it does not play a major role in resynthesizing ATP, except during times of 
metabolic distress when accumulation of ADP pushes the near equilibrium reaction 
towards products in an attempt to restore the ATP:ADP ratio. Although the production of 
ATP is minimal, this reaction is another line of defense, preventing a drastic change in 
the all-important ATP:ADP ratio (Tiidus et al., 2012). The reaction proceeds at an 
substantial rate during exercise, and is rendered more effective by the subsequent removal 
AMP (Woledge et al., 1985). AMP deaminase (Equation XVII) irreversibly removes the 
amino group from the base adenine of AMP produced in the AK reaction, yielding 
ammonia (NH3) and inosine monophosphate (IMP).  
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𝐴𝑀𝑃                       !"#  !"#$%&#'"                     𝐼𝑀𝑃 + 𝑁𝐻! 
Equation XVII. AMP deaminase reaction. 
 
The irreversible deamination of AMP removes the product of the AK reaction, 
and drives the reaction forward through mass action to further diminish any increase in 
[ADP]. These two reactions work in concert during intense contractions, and are 
extremely important in maintaining optimal energy status in the muscle. 
2.5.5.5. Glycolysis and Lactate Dehydrogenase Reactions 
Much more complex than a single reaction, glycolysis (Equation XVIII) is the 
metabolic pathway for carbohydrate breakdown in all cells involving a sequence of 
enzyme-catalyzed reactions. 
 𝐺𝑙𝑦𝑐𝑜𝑔𝑒𝑛! + 3  𝐴𝐷𝑃 + 3  𝑃! + 2  𝑁𝐴𝐷! → 𝐺𝑙𝑦𝑐𝑜𝑔𝑒𝑛!!! + 2  𝑃𝑦𝑟𝑢𝑣𝑎𝑡𝑒 + 3  𝐴𝑇𝑃 + 2  𝑁𝐴𝐷𝐻 + 2  𝐻! 
Equation XVIII. Summary of the glycolysis pathway starting with glycogen. 
 
Glycolysis is referred to as anaerobic if the energy production does not require 
oxygen, and only relies on substrate-level phosphorylation, such as pyruvate being 
reduced to lactate in the cytosol (Equation XIX) – this is a major energy source of ATP 
for skeletal muscle during intense exercise conditions. 
 𝑃𝑦𝑟𝑢𝑣𝑎𝑡𝑒 + 𝑁𝐴𝐷𝐻 + 𝐻!              !"#$"$%  !"!!"#$%&'()&             𝐿𝑎𝑐𝑡𝑎𝑡𝑒 + 𝑁𝐴𝐷!   
Equation XIX. Lactate dehydrogenase reaction. 
 
Apparently, ATP consuming processes in skeletal muscle have preference as to 
their energy source. ATP for crossbridge cycling is supplied in equal proportion from 
glycolysis and the CK reaction (48 and 52%, respectively), while the ATP for EA was 
preferentially derived from glycolysis versus CK (61 and 39%, respectively) as measured 
through 31P-NMR (Baker et al., 1994).  
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2.5.6. Quantifying Anaerobic ATP Provision 
Measurement of steady state oxygen consumption, along with a quick calculation 
are all that is required to determine the aerobic contribution to ATP production; however, 
the process of quantifying anaerobic ATP provision is more laborious. Since ATP 
hydrolysis is speedily reversed at the expense of PCr, and the net biochemical reaction is 
PCr hydrolysis (Barclay, 1996), measuring the change in [PCr] is indicative of ATP 
consumption.  
 𝑇𝑜𝑡𝑎𝑙  𝐴𝑇𝑃  𝑃𝑟𝑜𝑣𝑖𝑠𝑖𝑜𝑛 = −∆ 𝑃𝐶𝑟 − 2∆ 𝐴𝑇𝑃 + 1.5∆[𝐿𝑎𝑐𝑡𝑎𝑡𝑒] 
Equation XX. Calculating total ATP provision from substrate level phosphorylation. 
 
In Equation XX, ΔPCr represents the ATP produced from the decline in muscle 
PCr content from rest. 1.5ΔLactate represents the ATP produced from the glycolytic 
production of lactate with a net gain of 1.5 ATP per lactate molecule generated, 
representing 3 ATP produced per glucose molecule derived from muscle glycogen. 
2Δ[ATP] represents the total ATP utilization from the stored ATP pool in resting muscle. 
The change in ATP concentration is doubled because the reduction in muscle ATP with 
exercise is theoretically equivalent to the increase in IMP. In other words, 2 ATP must be 
hydrolyzed to produce a net change of 1 ATP, since IMP is produced from AMP in the 
AMP deaminase reaction, which was a product of the adenylate kinase reaction, requiring 
2 ADP. Originally, those 2 ADP were produced from the hydrolysis of 2 ATP during 
ATPase reactions; however, the net decrease is only 1 ATP, as the adenylate kinase 
reaction was responsible for the production of 1 ATP (Tiidus et al., 2012). This equation 
is also referred to as high-energy phosphate consumption (HEPC), as discussed in 
previous sections.  
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2.6. Metabolic Consequences of Potentiation 
Work published throughout the previous two decades has produced equivocal and 
contradictory results, leaving the question largely unanswered: Does a relationship exist 
between RLC phosphorylation-mediated potentiation and metabolism? Equation 4 from 
the Brenner Two-State Model states that myosin ATPase rates are increased in proportion 
to the increased force produced by RLC phosphorylation; however, if potentiation 
augments the relationship between mechanical output of a muscle and the energetic input, 
it may have vast implications on the contractile economy of muscles in the working state. 
As the primary mechanism of RLC phosphorylation-mediated force potentiation is 
confined to fast twitch skeletal muscle, this section will not discuss slow twitch skeletal 
muscle. When considering all of the complexities inherent in the regulation of skeletal 
muscle contraction and chemical energy utilization, it seems helpful to approach this 
question by exploring the three plausible outcomes experimentation can lead to: (1) RLC 
phosphorylation has no effect on the economy of contraction (2) RLC phosphorylation 
increases the economy of contraction (3) RLC phosphorylation decreases the economy of 
contraction.  
2.6.1. Evidence of No Consequence 
If chemical energy consumption increases in proportion to the increase in work or 
force produced by fast twitch skeletal muscle in the potentiated state, there would be no 
demonstrable change in economy. Barsotti & Butler (1984) set out to determine whether 
RLC phosphorylation modulated the rate of chemical energy consumption using 
maximally stimulated rat EDL. Not surprisingly, they reported that elevated RLC 
phosphorylation had no effect on maximal twitch force or energy consumption (Barsotti 
& Butler, 1984). This result may be in part due to the stimulation paradigm that was 
selected. As discussed in previous sections, RLC phosphorylation increases twitch force, 
without an increase in tetanic force; thus, no increase in maximal force should have been 
expected. With muscle maximally activated, and no manifested force potentiation, the 
relationship between RLC phosphorylation and chemical energy usage cannot be 
accurately explored. 
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2.6.2. Evidence of Increased Economy 
 Increasing the force production of contraction to a greater extent than energy 
consumption during the potentiated state would suggest that RLC phosphorylation 
increases the economy of contraction. In this regard, Crow & Kushmerick (1982b) 
reported a correlation between a myosin RLC phosphorylation and reduced energy cost 
for isometric tetani in mouse fast twitch muscle. It was hypothesized that actin-myosin 
interaction can be down-regulated by reversible covalent modification of myosin light 
chains, as a form of thick filament regulation (Crow & Kushmerick, 1982c). If, indeed, 
RLC phosphorylation resulted in a decreased ATPase rate during isometric tetani, an 
increased economy would be extant. Downward regulation of actin-myosin turnover 
makes physiological sense during isometric contractions when their physiological utility 
is considered: While maintaining contraction of a mixed muscle type, the mechanical 
speed and power of fast fibers used for limb acceleration/rapid movements is no longer 
necessary or useful (Crow & Kushmerick, 1982b). Increased efficiency in the potentiated 
state seems possible, as RLC phosphorylation allows a specific level of force to be 
maintained at a lower [Ca2+]. If a smaller ICT is required to produce the same amount of 
force as a muscle in an unpotentiated state, the working muscle will consume less energy 
clearing Ca2+ from the myoplasm (i.e. SERCA) during the contractile cycle (Sweeney et 
al., 1993). There is also some evidence to suggest that motor unit firing rate is down 
regulated while the muscle is in the potentiated state (Adam, 2005; Inglis, Howard, 
McIntosh, Gabriel, & Vandenboom, 2011). Decreasing the neural drive in vivo 
compensates for the short-lived potentiation of twitch force, another situation which 
would allow a given level of force output to be maintained with less frequent stimulation; 
theoretically, reducing the energetic overhead required for Ca2+ cycling. 
2.6.3. Evidence of Decreased Economy 
 The most recent research conducted in this field claimed that post-tetanic 
potentiation in rat skeletal muscle increased the energetic cost to a larger extent than 
work; thus, reducing the economy of contraction (Abbate et al., 2001). There are several 
possible explanations as to why potentiation may lead to an increased energy cost. First 
and foremost, phosphorylation of the RLC still requires an initial investment of ATP, as 
   44 
discussed in previous sections, the phosphorylation of upwards of 50% of RLCs in fast 
twitch muscle may be a costly endeavor, resulting in a large energetic overhead for the 
working muscle. Secondly, it is clear that complex interactions between RLC 
phosphorylation and muscle energetics exist. Any changes in the contractile function of 
the myofilament may be responsible for the reported increase in energy turnover, and it is 
suspected that there are metabolism-related alterations in crossbridge function during 
contraction (Stull et al., 2011). Although the fraction of cycling crossbridges transitioning 
to the force-generating state (𝑓!"") increases with RLC phosphorylation, this may be 
accompanied by a reduced efficiency of the crossbridges. Ultimately, it is possible that 
there is a decreased mechanical output for each ATP hydrolyzed in the potentiated state, 
resulting in a reduced efficiency of the working muscle (Abbate et al., 2001). 
Overall, evidence has been presented supporting each of the three possible 
relationships between RLC phosphorylation mediated force potentiation and energy 
consumption. Considering all lines of reasoning, it seems most plausible that RLC 
phosphorylation may increase the contractile economy of the working muscle in vivo due 
to a reduction in energetic overhead of Ca2+-cycling (i.e. a reduced EA) facilitated by 
increasing the Ca2+-sensitivity of the contractile apparatus.  
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3. Statement of Problem 
Conflicting evidence has been reported for the relationship between contractile 
economy and RLC phosphorylation. The biochemical processes responsible for the 
majority of skeletal muscle energy consumption (i.e. SERCA, myosin ATPase and Na+-
K+ ATPase) have all been thoroughly described in past physiological research; however, 
little attention has been paid to the energetic cost of phosphorylating myosin RLCs and 
the cost of the accompanied force potentiation. The biochemical properties of the RLC 
phosphorylation system seem ideal for a modulatory mechanism, because the system 
should consume little energy; yet, phosphorylation of the RLCs still requires a continual 
investment of ATP increasing the energetic overhead, specifically the EA, of the working 
muscle. Augmenting the relationship between mechanical output of a muscle and the 
metabolic input through RLC phosphorylation-mediated potentiation, would directly 
impact the economy of muscle contraction, and give insight into the physiological utility 
of this modulatory mechanism. Previous research produced equivocal, and occasionally 
contradictory results; thus, an investigation into this area is required to advance our 
knowledge of the bioenergetics of RLC phosphorylation-mediated force potentiation. 
This gap in the literature can be attributed to the previous lack of an animal model 
that could serve as a negative control for RLC phosphorylation, since any stimulation and 
subsequent Ca2+ release will result in fractional activation of skMLCK. Recent advances 
in our field have led to the development of a skMLCK-/- mouse, which is currently 
exclusive to our laboratory in the Centre for Bone and Muscle Health at Brock 
University, allowing us to definitively parse out the effects of RLC phosphorylation. 
3.1. Purpose 
The primary purpose of this study is to determine the effect of RLC 
phosphorylation-mediated force potentiation on the economy of isometric contraction of 
fast twitch skeletal muscle. The secondary purpose of this study is to determine the 
quantity of energy consumed by skMLCK throughout the phosphorylation cycle of 
myosin RLCs during a low-frequency conditioning stimulus; thus, determining the 
contribution of RLC phosphorylation to the activation energy turnover (EA) of fast twitch 
skeletal muscle.  
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3.2. Hypotheses 
We hypothesized that Wildtype muscles, with an intact RLC phosphorylation 
mechanism, would be more economical than skMLCK-/- muscles. It was predicted that 
Wildtype muscles would consume more energy in the potentiated state than skMLCK-/ 
muscles, but the force potentiation displayed by Wildtype muscles would be greater than 
the associated increase in energy consumption. Additionally, we hypothesized that the 
energetic overhead associated with RLC phosphorylation would be negligible (i.e. below 
level of detection) so that Wildtype and skMLCK-/- muscle EA would not differ. 
The following are observations expected during experimentation: 
1. RLC phosphate content will be significantly higher in Wildtype muscles than 
skMLCK-/- muscles. 
2. Wildtype muscles will display significantly higher twitch force potentiation than 
skMLCK-/- muscles 
3. Wildtype muscles will perform more isometric work, as estimated by the force-
time integral (FTI), than skMLCK-/- muscles.  
4. Wildtype muscles will consume more energy during the contractile experiments 
than skMLCK-/- muscles. 
5. EA will not differ between Wildtype and skMLCK-/- muscles.  
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3.3. Rationale 
A submaximal stimulation paradigm was chosen in an attempt to optimize 
fractional activation of skMLCK, while minimizing the negative effects of metabolic 
byproducts. Submaximal stimulation avoids super-physiological stimulation of the 
muscle, which is quite possible in an in vitro set up, and should prevent an unrealistic 
overconsumption of energy from SERCA, as well as preventing Pi accumulation that may 
ultimately inhibit Ca2+ release during times of metabolic stress (MacIntosh et al., 2012). 
A noticeable reduction in Ca2+ release does occur during repeated muscle activation, 
either through reduced availability after saturating myoplasmic Ca2+ buffers or by 
regulating processes of release (Allen, Lamb, & Westerblad, 2008). Fortunately, RLC 
phosphorylation-mediated potentiation allows for increased force production at any given 
submaximal [Ca2+], permitting a decrease in Ca2+ release without sacrificing force 
production, with the advantage of a lower SERCA activity and a reduced ATP usage 
(MacIntosh et al., 2012). The same Ca2+4-CaM complex that activates skMLCK can also 
inhibits Ca2+ release; thus, muscle is actually capable of simultaneously decreasing Ca2+ 
release and preserving contractile function through increasing Ca2+ sensitivity (MacIntosh 
et al., 2012), which may lead to an increased economy of contraction in muscles with an 
intact myosin RLC phosphorylation mechanism. 
Since both Wildtype and skMLCK-/- muscles are subjected to the same electrical 
stimulation, and thus may have an identical ICT, there should be no differences in energy 
consumption by SERCA or Na+-K+ ATPase between genotypes. Theoretically, RLC 
phosphorylation-induced loss of helical ordering of myosin heads will increase the 
number of crossbridges in the force producing state, and lead to an increased force 
production. Overall, considering an increased force output and a proportional increase in 
myosin ATPase energy consumption, accompanied by no alteration in EA, the mechanical 
output should be increased to a greater extent than the total energetic input, ultimately 
improving contractile economy. 
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4. Methods 
4.1. Animals 
SkMLCK-/- mice (19.4 ± 0.7 g, 8-12 weeks old, n = 20) were obtained from our 
colony, established by breeder pairs graciously donated by Dr. James Stull at the 
University of Texas Southwestern Medical Center. These mice were originally generated 
from C57BL/6 mice by methods previously described by Zhi et al. (2005). Wildtype 
C57BL/6 mice (19.4 ± 0.3 g, 8-12 weeks old, n = 20) were purchased from Charles River 
Laboratories (Saint Constant, QC). All mice were housed for a minimum of 1 week at 
room temperature on a 12-hr:12-hr light:dark cycle in the Brock University Ventilated 
Housing Unit of the Comparative Bioscience Facility. Standard mouse chow (5015, 
LabDiet, Aberfoyle, ON) and water were ingested ad libitum. Mice from each genotype 
were randomly assigned to either the Control or BTS condition (Figure IX). This study 
was approved by the Brock University Animal Care Committee and conforms to the 
standards of the Canadian Council for Animal Care (Protocol # 14-09-01). 
 
 
Figure IX. Allocation of isolated EDL muscles to experimental groups. 
 
4.2. Materials 
BTS, manufactured by Tocris Bioscience, was purchased from Cedarlane Labs 
(Burlington, ON), secondary antibody was purchased from Santa Cruz Biotechnology 
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(Dallas, TX), and all other reagents were purchased from Sigma-Aldrich (Oakville, ON) 
or BioRad Laboratories (Mississauga, ON). Myosin RLC antibody was a generous gift 
from Dr. James Stull.  
4.3. Muscle Model and Experimental Apparatus 
Contractile experiments were conducted using a 1200a In Vitro Muscle Testing 
System from Aurora Scientific Inc. (Aurora, Ontario), capable of accurately controlling 
muscle length, shortening speed, and temperature. The mouse extensor digitorum longus 
(EDL) muscle was chosen as a representative fast twitch muscle (Figure X), as it is 
comprised almost entirely of the fast myosin isoforms that display RLC phosphorylation 
and force potentiation (Vandenboom et al., 2013): 8.6% type IIA, 30.3% type IIX, and 
59.7% type IIB (Gittings, Huang, Smith, Quadrilatero, & Vandenboom, 2011). Equally 
important in the decision to use the in vitro EDL muscle model was the viability of the 
tissue once it had been excised. The EDL is small enough in diameter to ensure that most 
fibres remain viable by receiving sufficient oxygenation and substrate delivery purely 
through diffusion (Barclay, 2005).  
 
Figure X. The EDL of the mouse hind limb (A) is composed of predominately fast fibres (B). 
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Excised muscles were suspended in a jacketed vertical organ bath (Radnoti LLC, 
Monrovia, CA) containing continuously oxygenated Tyrode’s solution (molar 
composition described in Section 4.4) maintained at constant temperature using an 
Isotemp 4100 R20 circulator (Fisher Scientific Company, Ottawa, ON). Field stimulation 
was applied using flanking platinum electrodes driven by a Model 701B biphase 
stimulator (Aurora Scientific, Inc. [ASI]). Muscle length was measured using digital 
vernier calipers with LCD display. All contractile data were sampled and collected at 
2000 Hz from a 305B servomotor acquired through a 604C analog-to-digital interface, 
and controlled by a dual-mode lever system (ASI). Data acquisition and basic analysis 
was performed using ASI 600a software (Version 1.60) and further examined using Excel 
(Microsoft Canada Co., Mississauga, ON). 
 
 
Figure XI. Schematic diagram of the in vitro muscle testing system used for contractile 
experiments.  
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4.4. Surgical Procedures and Preparation of Muscle Tissue 
On the day of surgery, a stock solution of sodium pentobarbital (Euthanyl, 240 
mg/mL: Bimedia, Cambridge, ON) was diluted 1:50 with sterile saline to obtain a 
working concentration of 4.8 mg/mL. Animals were weighed to the nearest 0.01 g, and 
then sedated with an intraperitoneal (IP) injection of sodium pentobarbital (anesthetic 
dose: 60 mg/kg body weight) using a 27.5 gauge needle. Surgery commenced only once 
an adequate depth of sedation was reached, as determined by the absence of the pedal 
withdraw reflex (i.e. toe-pinch). Bilateral EDL muscles were surgically isolated from 
each hind limb of Wildtype and skMLCK-/- mice after the tibialis anterior was removed, 
and a non-absorbable braided silk 4-0 suture (Surgical Specialties Corporation, Reading, 
PA) was tied to the proximal and distal tendons using a double square knot. From each 
animal, one EDL was mounted into the experimental apparatus immediately (<5 s) to 
maintain tissue viability, while the contralateral muscle was suspended in an adjacent 
bath to equilibrate and remain unstimulated, serving as a resting control. Following EDL 
dissection, the animals were euthanized humanely by an overdose of sodium 
pentobarbital delivered via intracardiac injection (euthanasia dose: 120 mg/kg body 
weight) and disposed of according to the established Brock University Comparative 
Bioscience Facility protocol. 
Tyrode’s solution, a physiological saline solution, was used in all contractile 
experiments to create a favorable environment for muscle contraction, by providing 
muscle tissue the essential substrates and ions present in vivo, as well as an isotonic 
environment in which to survive. Final ionic concentrations were (in mM): 121.0 NaCl, 
5.0 KCl, 24.0 NaHCO3, 0.4 NaH2PO4, 0.5 MgCl2, 1.8 CaCl2, 5.5 D-Glucose, and 0.1 
EDTA. The solution was continuously gassed with 95% O2 and 5% CO2 using a 
scintillated glass dispersion valve (Radnoti LLC, Monrovia, CA), resulting in a pH of 
~7.4. Temperature was maintained at 25.0 ± 0.1 ℃.  
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4.5. Contractile Experiment Protocol 
The following experiments were conducted as a means of sequentially activating 
skMLCK, determining the relative RLC phosphorylation-mediated potentiation of twitch 
force in mammalian fast twitch skeletal muscle, as well as determining the Force Time 
Integral (FTI) to estimate isometric work.  
4.5.1. Equilibration and Determination of Optimal Length  
Initially, after the EDL muscle was set to a resting tension of ~3-5 mN, it was 
stimulated to produce three tetanic contractions (150 Hz for 300 ms, 60 s apart) forceful 
enough to remove any compliance within the muscle, and tighten suture knots to prevent 
slippage of the tendon-suture unions during future contractions. Subsequently, a single 
twitch was applied at 0.05 Hz while successively increasing current intensity (mA), to 
determine the current required to produce maximal twitch force. To guarantee maximal 
excitation of all muscle fibres, the stimulus intensity was then increased by ~25%, where 
it remained for the duration of each experiment. After establishing the preliminary 
settings, the muscle was subjected to standard 30-minute equilibration period designed to 
return the muscle to baseline conditions after the rigors of surgical stress. During this 
time, the EDL was stimulated to produce a single twitch, once every 3 min, over 30 min 
to monitor the recovery of twitch force. Equilibration was reached at the point where 
there were no further changes in the magnitude of twitch force. 
Following the equilibration period, the optimal length (Lo), i.e. the length at which 
maximal twitch force is produced, was determined by stimulating the muscle at various 
lengths. The resting tension of the muscle was originally set to 0 mN (i.e. just taut length) 
and stimulated to produce a single twitch. Thereafter, twitches were elicited while resting 
tension was increased at 1.0 mN intervals up to 20 mN (~2.0 g of force). Force traces 
were analyzed and the resting tension at which active twitch force (i.e. total force minus 
passive force) reached a maximum (Pt), as well as 70% of maximal twitch force (i.e. 0.7 
Pt) were determined. Muscle length was measured using digital vernier calipers with 
resting tension adjusted to Pt, and was documented as Lo . This length was used as the 
reference length for all subsequent steps. Resting tension was then adjusted to 0.7 Pt, and 
muscle length was measured. The muscle remained set to 0.7 Pt, corresponding to 0.9 Lo 
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on average, for the remainder of the contractile experiment. Following these standard 
preliminary procedures, the contractile experiment was conducted.  
4.5.2. Contractile Experiment  
Immediately following the equilibration period and determination of Lo, the 
muscle remained quiescent for a further 80 min period. The muscle was then subjected to 
the 10 Hz 15 s potentiating stimulation, producing a total of 150 individual twitches. 
Each experiment was officially terminated when the EDL was rapidly frozen (<2 s) using 
tongs pre-cooled in liquid nitrogen, and stored at -80°C for future biochemical analysis. 
Prior to the mounting of each EDL muscle, the Tyrode’s solution was replaced with a 
fresh aliquot and given sufficient time to equilibrate (~15 min). 
BTS, which inhibits Pi release from the actin-myosin-ADP-Pi complex and 
decreases myosin’s affinity for actin (Shaw, Ostap, & Goldman, 2003), was used in a 
parallel set of experiments where crossbridge cycling was pharmacologically inhibited. 
This was done to partition energy consumption into contractile and non-contractile 
components. BTS was solubilized in dimethyl sulfoxide (DMSO) to create a 25 mM 
stock solution. A small volume of BTS stock solution was added to the organ bath 
following preliminary procedures (final concentration = 0.1% vol/vol), yielding a final 
concentration of 25 µM. Muscles were incubated in the presence of BTS for 80 minutes 
before the contractile experiment began; a time that pilot experiments revealed depressed 
~95% of force production. 
4.5.3. Quantifying Force Potentiation 
Relative force potentiation was quantified as the ratio of final twitch force to 
initial twitch force, producing a value that reflects an increase or decrease in twitch force 
relative to baseline measures. During the potentiating stimulation, a rapid increase in 
force occurred in the initial 0.5 s due to partial fusion of contractile force; thus, twitch 
force was normalized to the twitch occurring at 0.5 s (i.e. the 6th twitch) (Ryder, Lau, 
Kamm, & Stull, 2007).  
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4.5.4. Kinetic Analysis 
Force traces were analyzed at predetermined time-points (initial twitch, 25th 
twitch, 50th twitch, and final twitch) to gain insight into how contractile kinetics changed 
throughout the 15 s potentiating stimulus. The following analyses were made: Time to 
peak tension (TPT), half-relaxation time (RT1/2), average rate of force development (+ 
dP/dt), and average rate of relaxation (- dP/dt).   
4.5.5. Quantifying Force-Time Integral (FTI) 
Since the twitches were performed under isometric conditions, quantifying total 
work performed during the potentiating stimulus is impossible, as the force produced was 
not completed over a distance; thus, the force-time integral (FTI) was calculated to 
estimate isometric work. FTI is the area under the force-time curve, and was calculated 
using the trapezoidal method according to Equation XXI. Calculations were completed 
using Microsoft Excel. 
 𝑓 𝐹 𝑑𝐹   ≈ ∆𝑡2 𝐹! + 2𝐹! + 2𝐹! +⋯+ 2𝐹!!! + 𝐹!!"###!  
Equation XXI. Calculating the area under the force-time curve. 
 
4.6. Biochemical Analysis of Skeletal Muscle Tissue 
Each of the following biochemical analyses were completed using an entire EDL 
for sample preparation rather than sectioning muscles to obtain multiple samples from 
each, as whole muscle homogenate values reflect the spatially averaged change across all 
fibers present (Allen, 2008). 
4.6.1. Quantifying Myosin RLC Phosphate Content 
Myosin RLC phosphate content was quantified by Urea/Glycerol Polyacrylamide 
Gel Electrophoresis (-PAGE) followed by immunoblotting. Stimulated muscles and their 
contralateral controls were removed from -80°C storage for analysis and homogenized 
using 3.0 mL tissue grinders with glass pestles (Wheaton Industries Inc., Millville, NJ). 
Proteins were precipitated in 10% trichloroacetic acid (TCA), solubilized in a urea-based 
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sample buffer, and run through an ~8% polyacrylamide gel with glycerol added for 
density at 400 V for 85 min. Non-phosphorylated RLCs were separated from mono- and 
diphosphorylated RLCs based upon charge, with phosphorylated RLCs migrating further 
through the gel. Proteins were then transferred to nitrocellulose membranes (0.45 µm 
pore size; Bio-Rad Laboratories, Mississauga, ON) at 25 V for 1 hr, and probed with 
polyclonal primary antibodies raised in rabbits to purified skeletal RLCs. Goat anti-rabbit 
horseradish peroxidase (HRP)-conjugated secondary antibodies (sc-2004; Santa Cruz 
Biotechnology, Dallas, TX) were then used in conjunction with the Amersham ECL 
Western Blotting System (GE Life Sciences, Mississauga, ON). Blots were processed on 
a FluorChem 5500 Western Blot Imaging System (Alpha Innotech Corporation, San 
Leandro, CA) using AlphaEase software, and quantitative measurements (mol P/mol 
RLC) were made using Image Studio Lite software (LI-COR Biotechnology, Lincoln, 
NE). 
4.6.2. Quantifying High Energy Phosphate Consumption 
Muscles were removed from -80°C storage and lyophilized by a FreeZone 4.5 
Liter Benchtop Freeze Dry System (Labconco, Kansas City, MO) for a minimum of 6 hrs 
to ensure removal of all water. After the silk sutures remaining from the contractile 
experiment were removed, the muscles were dissected free of connective tissue and 
blood, then powdered in a glass petri dish using stainless steel tweezers. Powder was 
aliquoted to 1.5 mL microcentrifuge tubes. Metabolites were extracted from aliquots of 
lyophilized tissue using 0.5 M perchloric acid (HClO4), and neutralized with 2.3 M 
potassium carbonate (KHCO3). The concentrations of metabolites were analyzed in 
triplicate in opaque black polypropylene 96-well microplates (Greiner Bio-One America 
Inc., Monroe, NC) using fluorometric techniques as previously described (Bergmeyer, 
Bergmeyer, & Grassl, 1983; Harris, Hultman, & Nordesjö, 1974). 
 Three specific assays were used to identify the concentration of the metabolites 
of interest, including ATP, phosphocreatine (PCr), creatine (Cr), and lactate. To adjust for 
variability in solid non-muscle constituents, all raw metabolite values were normalized to 
total Cr content (i.e. divided by the sum of the individual muscle’s PCr + Cr, then 
multiplied by mean total Cr content for the all muscle samples) (Zhang et al., 2006). 
High-Energy Phosphate Consumption (HEPC), a measure of ATP turnover determined 
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through anaerobic ATP production, was calculated for each group from changes in 
concentrations metabolites using the following formula: 
 𝐻𝐸𝑃𝐶 = −∆𝑃𝐶𝑟 − 2∆ 𝐴𝑇𝑃 + 1.5∆𝐿𝑎𝑐𝑡𝑎𝑡𝑒 
Equation XXII. Calculating high-energy phosphate consumption. 
 
The change (Δ) signifies the differences in metabolite concentrations between the 
experimental muscle and its contralateral resting control.  
 
4.6.3. Quantifying Contractile Economy 
Contractile economy was defined as the ratio of mechanical output to metabolic 
input, i.e. FTI to HEPC. The quantity is given in millinewton-seconds per micromole of 
high-energy phosphate (mNs/µmol ~P). (De Haan et al., 1986). 
 𝐸𝑐𝑜𝑛𝑜𝑚𝑦  (𝑚𝑁𝑠 ∙ 𝜇𝑚𝑜𝑙  ~𝑃!!) = 𝐹𝑇𝐼  (𝑚𝑁𝑠)𝐻𝐸𝑃𝐶  (𝜇𝑚𝑜𝑙  ~𝑃!!) 
Equation XXIII. Calculating contractile economy of skeletal muscle. 
 
4.7. Experimental Timeline 
 
Figure XII. Overview of the timeline of experimental procedures. 
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Figure XIII. Contractile experiment timelines for Control (A) and BTS (B) conditions. Arrows 
indicate freezing of muscle for biochemical analysis. 
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4.8. Data Presentation and Statistical Analyses 
Data were initially screened for outliers, and the assumptions for parametric 
statistical tests were checked. The assumption of normal distribution was checked using 
Shapiro-Wilk Normality Tests, and F-tests were used to check the assumption of equality 
of variances. Following these preliminary steps, the appropriate analysis was selected for 
each set of data. 
One-way ANOVAs were used to examine differences among conditions in all 
anthropometric measures, including age, body mass, muscle mass, muscle length, and 
physiological cross-sectional area. Post-hoc analyses were conducted using Tukey’s 
HSD.  
A two-way repeated measures ANOVA was conducted to evaluate the effect of 
skMLCK expression [Wildtype or skMLCK-/-] and potentiating stimulation [Resting or 
Stimulated] on isometric twitch force in the control condition. Post-hoc analyses were 
conducted using Sidak’s correction.  
When checked for the assumptions of a t-test, it was determined that skMLCK-/- 
potentiation values were not normally distributed and the assumption of homogeneity of 
variances was violated. Thus, a non-parametric alternative, a one-tailed Mann-Whitney 
rank sum test, was conducted to determine the effect of skMLCK expression [Wildtype 
or skMLCK-/-] on force potentiation (i.e. relative isometric force production).  
Two-way repeated measures ANOVAs were conducted to examine differences 
among conditions in all kinetic measurements, including peak twitch force, time to peak 
tension, half-relaxation time, rate of force development, and rate of relaxation. Post-hoc 
analyses were conducted using Sidak’s correction.  
A one-tailed unpaired t-test was conducted to examine the effect of skMLCK 
expression [Wildtype or skMLCK-/-] on total FTI, and another one-tailed unpaired t-test 
was conducted to examine the effect of skMLCK expression [Wildtype or skMLCK-/-] on 
residual FTI during myosin II ATPase inhibition via BTS.  
A two-way ANOVA was then conducted to compare the effect of skMLCK 
expression [Wildtype or skMLCK-/-] and potentiating stimulation [Resting or Stimulated] 
on myosin RLC phosphate content. Post-hoc analyses were conducted using Tukey’s 
HSD.  
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One-tailed unpaired t-tests were conducted to examine the effect of skMLCK 
expression [Wildtype or skMLCK-/-] on total energy consumption (ETotal), activation 
energy turnover (EA), and the crossbridge component of energy consumption (EXB) 
during the 15 s potentiating stimulus.  
Finally, a one-tailed unpaired t-test was conducted to determine the effect of 
skMLCK expression [Wildtype or skMLCK-/-] on contractile economy. The assumption 
of homogeneity of variances was violated, thus Welch’s correction was employed. All 
statistical analyses were conducted using GraphPad Prism 6 (La Jolla, CA), and the level 
of significance was set at P < .05. All values are presented as means ± standard error of 
the mean (SEM) unless otherwise stated.  
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5. Results 
5.1. Animal Characteristics 
Characteristics of the sampled animals are displayed in Table I. Results of the 
ANOVAs revealed significant differences between groups for age, [F(3, 26) = 4.48, P = 
.012, η2 = .3413]. SkMLCK-/- BTS mice were significantly younger than Wildtype 
Control mice (P = .012), as well as Wildtype BTS mice (P = .042). Although these two 
differences in ages are statistically significant, the age of all mice within the present study 
only ranged a mere 10.6 days. Inclusion criteria dictated that all mice be sexually mature 
adults (Fox et al., 2006); thus, these differences are negligible and are presumed not to 
impact any findings. 
Although there were no significant differences in body mass between groups, a 
significant difference between muscle masses was evident, [F(3, 26) = 3.058, P = .046, η2 
= .261]. It was determined that muscles in the skMLCK-/- Control condition were larger 
than those in the skMLCK-/- BTS condition (P = .032). While Lo did not differ between 
groups, a significant difference in PCSA was determined [F(3, 26) = 3.37, P = .033, η2 = 
.280], as this value is calculated using the muscle masses already determined to be 
different. Once again, muscles in the skMLCK-/- Control group had a larger PSCA than 
muscles in the skMLCK-/- BTS conditions (P = .024). 
 
Table I. Anthropometric characterization of mice used for contractile experiments. 
 Age n Body Mass 
Muscle 
Mass Lo PCSA 
 (days) (mice) (g) (mg) (mm) (mm2) 
Wildtype       
Control 73.1 ± 1.6a 8 19.9 ± 0.2 8.7 ± 0.6ab 12.8 ± 0.1 1.62 ± 0.1ab 
BTS 71.7 ± 3.3a 7 19.0 ± 0.6 9.2 ± 0.6ab 12.8 ± 0.2 1.73 ± 0.1ab 
skMLCK-/-       
Control 67.4 ± 2.0ab 8 20.7 ± 1.6 10.0 ± 0.7a 12.6 ± 0.2 1.92 ± 0.1a 
BTS 62.4 ± 1.9b 7 18.0 ± 0.9 7.5 ± 0.5b 12.4 ± 0.3 1.47 ± 0.1b 
Values are means ± SEM; BTS, N-benzyl-p-toluene sulfonamide; n, number of mice; Lo, optimal length; 
PSCA, physiological cross-sectional area; Means with different letters are significantly different from each 
other (Tukey’s HSD, P < .05).  
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5.2. Contractile Data 
 
Figure XIV. Representative force traces of skMLCK-/- (A) and Wildtype (B) muscles 
during repetitive low-frequency potentiating stimulation.  
5.2.1. Absolute Twitch Force 
It was hypothesized that initial twitch force would not differ between Wildtype 
and skMLCK-/- muscles, and that 15 s of low-frequency stimulation would result in 
staircase potentiation of twitch force in both genotypes. Results of the two-way repeated 
measures ANOVA indicated a significant interaction between skMLCK expression and 
potentiating stimulation [F(1,14) = 19.15, P = .0006, η2 = .045]. The potentiating 
stimulation combined with skMLCK expression significantly increased Wildtype twitch 
force (P < .0001), while potentiating stimulation in the absence of skMLCK did not 
impact twitch force of skMLCK-/- muscle (P = .285). There was no significant difference 
between initial twitch force of Wildtype and skMLCK-/- groups (P = .340); however, 
following the potentiating stimulation, Wildtype mean final twitch force was 33% greater 
than skMLCK-/- (P = .004). Means ± SEM are provided in Table II. 
 
Table II. The effect of a potentiating stimulus on isometric force production. 
 Initial (mN) Final (mN) 
Wildtype Control 45.8 ± 3.5a 56.3 ± 2.4b 
skMLCK-/- Control 40.2 ± 2.8a 42.2 ± 3.0a 
Values are means ± SEM, n = 8; Initial, twitch force determined from the twitch occurring at 0.5 s (i.e. the 
6th twitch); Final, 150th twitch. Means with different letters are significantly different from each other 
(Sidak’s correction, P < .01).  
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5.2.2. Relative Force Potentiation 
It was hypothesized that Wildtype muscles would display greater isometric force 
potentiation (final twitch/initial twitch) than skMLCK-/- muscles. Results of the one-tailed 
Mann-Whitney rank sum test indicated that Wildtype force potentiation (Mdn = 1.22, n = 
8) was greater than skMLCK-/- force potentiation (Mdn = 1.05, n = 8) forces; U = 6, Z = -
2.741, P = .002, r = -.685. 
 
Figure XV. Presence of skMLCK potentiates twitch force during repetitive low-frequency 
stimulation. (A) The interaction between the effects of repetitive low-frequency stimulation and 
skMLCK content on absolute twitch force in skMLCK-/- and Wildtype muscle; ** indicates P = 
.004 vs. skMLCK-/- Final; **** indicates P < .0001 vs. Wildtype Initial. (B) Potentiation of 
relative twitch force (final twitch/initial twitch) resulting from repetitive low-frequency 
stimulation; ** indicates P = .002.  
5.2.3. Twitch Kinetics 
Various kinetic analyses were conducted at several time points throughout the 
potentiating stimulation: The initial twitch, 25th twitch, 50th twitch, and final twitch. 
Analyses included peak twitch force (Pt), time to peak tension (TPT), half-relaxation time 
(RT1/2), rate of force development, and rate of relaxation. A repeated measures ANOVA 
was run for each genotype to compare the various time points, while unpaired t-tests 
compared the two genotypes at each individual time point. Means ± SEM, as well as the 
results of these tests are summarized in Table III.  
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Table III. Kinetic characteristics of twitches sampled throughout the potentiating stimulus. 
 Initial Twitch 25th 50th 150th  
Pt (mN)     
Wildtype 45.8 ± 3.5a 45.3 ± 3.2a 49.67 ± 3.0b 56.3 ± 2.4c 
skMLCK-/- 40.2 ± 2.8ac 37.5 ± 2.7b* 38.92 ± 2.8ab* 42.2 ± 3.0c* 
TPT (ms)     
Wildtype 18.3 ± 0.3a 16.3 ± 0.3b 16.0 ± 0.3c 15.8 ± 0.3c 
skMLCK-/- 17.3 ± 0.4a* 15.6 ± 0.2b* 14.9 ± 0.3c* 14.4 ± 0.4c* 
RT1/2 (ms)     
Wildtype 12.1 ± 0.4a 8.1 ± 0.2b 7.6 ± 0.3b 9.6 ± 0.5c 
skMLCK-/- 10.9 ± 0.3a* 7.6 ± 0.3b 6.9 ± 0.2b 7.3 ± 0.2b* 
+dP/dt (mNms-1)     
Wildtype 2.5 ± 0.2a 2.7 ± 0.2b 3.1 ± 0.2c 3.6 ± 0.2d 
skMLCK-/- 2.3 ± 0.1a 2.4 ± 0.2a 2.6 ± 0.2b* 2.9 ± 0.2c* 
-dP/dt (mNms-1)     
Wildtype 1.9 ± 0.2a 2.8 ± 0.2b 3.3 ± 0.1c 3.0 ± 0.1b 
skMLCK-/- 1.9 ± 0.2a 2.5 ± 0.2b 2.9 ± 0.2c 2.8 ± 0.2c 
Values are means ± SEM; n = 8; Pt, peak isometric twitch force; TPT, time to peak tension; RT1/2, half-
relaxation time; +dP/dt (mNms-1), rate of force development; -dP/dt (mNms-1), rate of relaxation. Means 
with different letters are significantly different within row (within Genotype; Sidak’s correction, P < .05); * 
indicates that skMLCK-/- is significantly different than Wildtype at that time point (unpaired t-test, P < .05).  
 
 
Figure XVI. Traces of isometric twitches evoked from skMLCK-/- (A) and Wildtype (B) muscles sampled 
throughout the 15 s of repetitive low-frequency stimulation. 
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5.2.4. Force-Time Integral 
5.2.4.1. Control Groups 
It was hypothesized that in the control groups, Wildtype muscles would perform 
more isometric work than skMLCK-/- muscles, as estimated by the total force-time 
integral (FTI). Results of the one-tailed unpaired t-test indicated that the mean Wildtype 
FTI (152.7 ± 11.6 mNs, n = 8) was larger than the mean skMLCK-/- FTI (105.8 ± 7.9 
mNs, n = 8); [t(14) = 3.40, P = .002, R2 = .452]. 
5.2.4.2. BTS Groups 
It was hypothesized that in the BTS treated groups, Wildtype muscles would 
perform more isometric work as estimated by the force-time integral (FTI) than 
skMLCK-/- muscles. Results of the one-tailed unpaired t-test indicated that during myosin 
II ATPase inhibition via BTS the mean FTI of Wildtype muscles (17.01 ± 1.7 mNs, n = 
7) was larger than the mean of skMLCK-/- muscles (10.21 ± 0.8 mNs, n = 7); [t(12) = 
3.63, P = .002, R2 = .523]. 
 
Figure XVII. Effects of skMLCK expression and BTS incubation on isometric work performed during 
repetitive low-frequency stimulation of isolated mouse EDL at 25 C. Open bars, skMLCK-/-; Closed bars, 
Wildtype. Values are means ± SEM for each group (n = 7-8). ** indicates P < .01; **** indicates P < .0001 
(Tukey’s HSD).   
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5.2.5. Effects of BTS Incubation on Force Production 
Following an 80 min incubation period, isometric twitch force of EDL muscles 
treated with BTS was abolished by 94.19 ± 1.14% and 94.73 ± 1.17% of the Wildtype 
and skMLCK-/- Control groups, respectively (n = 7).  BTS treatment also inhibited the 
FTI by 88.2 ± 1.8% and 90.4 ± 0.8% of that in the Wildtype and skMLCK-/- Control 
groups, respectively (n = 7). 
 
Figure XVIII. An 80 min incubation in 25 µM BTS abolishes ~94% of twitch force production of mouse 
EDL. (A) The time course of myosin II ATPase inhibition via BTS is the same for Wildtype and skMLCK-
/- muscles. (B) Single twitches stimulated 5 min apart, depicting the depression of force during BTS 
incubation (only Wildtype traces shown). Representative traces of the low-frequency repetitive stimulation 
during control incubations (C) and BTS inhibition of myosin II ATPase (D) of a Wildtype muscle. BTS 
treated FTI is barely distinguishable from the X-axis. 
5.3. Myosin RLC Phosphorylation 
It was expected that 15 s of low-frequency stimulation would increase myosin 
RLC phosphate content of isolated EDL muscles from Wildtype, but not skMLCK-/- 
mice. Additionally, it was believed that due to its specificity as a myosin II ATPase 
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inhibitor, BTS treatment would not affect phosphorylation of the myosin RLC. An initial 
two-way ANOVA was conducted, followed by post-hoc analyses using Tukey’s HSD, 
which revealed that no differences existed between any control condition and its matched 
BTS condition (P > .900). This evidence supported the hypothesis that myosin II ATPase 
inhibition via BTS has no effect on skMLCK-mediated phosphorylation of the myosin 
RLC; thus, Control and BTS groups were collapsed within Wildtype and skMLCK-/- 
genotypes to increase sample size. 
A new two-way ANOVA was then conducted with Control and BTS groups 
collapsed to compare the effect of skMLCK expression [Wildtype or skMLCK-/-], and 
potentiating stimulation [Resting or Stimulated] on myosin RLC phosphate content. 
Results of the ANOVA indicated a significant interaction between skMLCK expression 
and potentiating stimulation [F (1,20) = 75.82, P < .0001, η2 = .2236]. Post-hoc analyses 
using Tukey’s HSD revealed that in the absence of skMLCK, potentiating stimulation did 
not impact mean RLC phosphate content of skMLCK-/- muscle (P = .997). However, 
combining potentiating stimulation and skMLCK expression led to a 3-fold increase in 
RLC phosphate content in Wildtype muscle (P < .0001). Interestingly, resting Wildtype 
muscle had twice as much RLC phosphate content as skMLCK-/- muscle at rest (P = 
.026), and skMLCK-/- muscle after stimulation (P = .016). Means ± SEM are provided in 
Table IV, and example blots are depicted in Figure XIX.  
 
Table IV. RLC phosphate content of EDL muscles from Wildtype and skMLCK-/- mice 
collapsed across Control and BTS conditions 
 Resting Stimulated 
Wildtype 0.12 ± 0.01b 0.35 ± 0.01c 
skMLCK-/- 0.06 ± 0.01a 0.05 ± 0.01a 
Values are means ± SEM, n = 6. Values given in mol P/mol RLC. Resting and stimulated muscles were 
frozen and RLC phosphate content was analyzed using urea/glycerol PAGE with immunoblotting. Means 
with different letters are significantly different from one another (Tukey’s HSD, P < .05). 
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Figure XIX. Concomitant myosin RLC phosphorylation and isometric twitch force potentiation. (A) 
Representative urea/glycerol PAGE blot of non-phosphorylated and monophosphorylated myosin RLC of 
isolated EDL muscles from Wildtype and skMLCK-/- mice. One muscle was frozen after an 80 min 
equilibration period (Resting) while the contralateral muscle from the same animal was frozen after 15 s of 
potentiating stimulation that began immediately following the 80 min equilibration period (Stimulated) to 
determine the effects of skMLCK expression on myosin RLC phosphate content. (B) Two-way ANOVA of 
RLC phosphate content, values expressed as means ± SEM; n = 6. Open bars, Resting; Closed bars, 
Stimulated. (C) Two-way repeated measures ANOVA of relative isometric twitch force, values expressed 
as means ± SEM; n = 8. Open bars, Initial Twitch; Closed bars, Final Twitch.  
* indicates P < .05; *** indicates P < .001; **** indicates P < .0001. 
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5.4. Metabolite Concentrations 
5.4.1. Resting Levels 
Results of the two way ANOVAs revealed that no significant differences existed 
between genotypes or incubation conditions in resting concentrations of PCr (P > .954), 
Cr (P > .954), ATP (P > .286), or Lactate (P > .934). Means ± SEM are provided in 
Table V.  
Table V. Effect of BTS and skMLCK on metabolites in mouse EDL muscle in basal state. 
 PCr Cr ATP Lactate 
Wildtype     
Control 93.9 ± 1.1 17.8 ± 1.1 21.9 ± 0.6 2.84 ± 0.8 
BTS 94.7 ± 1.0 17.0 ± 1.0 23.6 ± 0.8 2.49 ± 0.8 
skMLCK-/-     
Control 95.6 ± 3.0 16.1 ± 3.0 23.4 ± 0.6 3.08 ± 0.8 
BTS 94.1 ± 3.4 17.6 ± 3.4 22.0 ± 0.6 2.49 ± 0.5 
Values are means ± SEM, n = 7 muscles. Values are given in µmol/g dry wt. BTS, N-benzyl-p-toluene sulfonamide, 
skMLCK, skeletal myosin light chain kinase; EDL, extensor digitorum longus; PCr, phosphocreatine; Cr, creatine. 
Muscles were incubated for 80 min at 25°C in the absence (Control) or presence of 25 µM BTS. At 80 min, muscles 
were immediately snap-frozen and stored at -80°C until analyzed. 
5.4.2. Stimulated Metabolite Levels 
Results of the two way ANOVAs revealed that no significant differences existed 
between genotypes or incubation conditions in stimulated concentrations of PCr (P > 
.063), Cr (P > .062), or ATP (P > .572). There was a significant effect of treatment on 
lactate concentration [F (1, 24) = 19.59, P = .002, η2 = .4099]. Wildtype Control muscles 
had significantly greater lactate concentrations after stimulation than Wildtype BTS (P < 
.004) and skMLCK-/- BTS muscles (P < .001). Means ± SEM are provided in Table VI.  
Table VI. Effect of BTS and skMLCK on metabolites in mouse EDL muscle after stimulation. 
 PCr Cr ATP Lactate 
Wildtype     
Control 59.6 ± 5.0 52.1 ± 5.0 23.2 ± 1.1 13.1 ± 0.8a 
BTS 71.1 ± 2.3 40.6 ± 2.3 22.1 ± 0.9 7.2 ± 1.1b 
skMLCK-/-     
Control 62.9 ± 2.6 48.8 ± 2.3 21.0 ± 1.1 10.1 ± 1.2ab 
BTS 71.4 ± 1.8 40.3 ± 1.8 22.0 ± 1.6 6.5 ± 1.7b 
Values are means ± SEM, n = 7 muscles. Values are given in µmol/g dry wt. BTS, N-benzyl-p-toluene sulfonamide, 
skMLCK, skeletal myosin light chain kinase; EDL, extensor digitorum longus; PCr, phosphocreatine; Cr, creatine.  
Muscles were incubated for 80 min at 25°C in the absence (Control) or presence of 25 µM BTS. At 80 min, muscles 
were stimulated (10 Hz, 15 s), then immediately snap-frozen and stored at -80°C until analyzed. Means with different 
letters are significantly different (Tukey’s HSD, P < .05).   
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Figure XX. Change in metabolite concentration between contralateral pairings of resting and stimulated 
EDL from Wildtype and skMLCK-/- mice, incubated in the absence (Control) or presence (BTS) of 25 µM 
BTS. Values are means ± SEM, n = 7 contralateral pairs. For each metabolite, means with different 
symbols are significantly different from one another (Tukey’s HSD, P < .05). 
5.4.3. Energy Consumption 
5.4.3.1. Total Energy Consumption (ETotal) 
 It was hypothesized that Wildtype muscles would consume more high-energy 
phosphates than skMLCK-/- muscles during the 15 s low-frequency potentiating 
stimulation. However, results of the one-tailed unpaired t-test indicated that there was no 
significant difference in energy consumed during the potentiating stimulus between 
Wildtype muscles (47.1 ± 6.9 µmol~P, n = 7) and skMLCK-/- muscles (48.1 ± 3.1 
µmol~P, n = 7); [t(12) = 0.134, P = .448, R2 = .001] 
5.4.3.2. Activation Energy Turnover (EA) 
It was hypothesized that Wildtype muscles would have a higher activation energy 
turnover than skMLCK-/- muscles. Results of the a one-tailed unpaired t-test revealed that 
there was no significant difference in activation energy turnover during the potentiating 
stimulus between Wildtype muscles (33.5 ± 3.6 µmol~P, n = 7) and skMLCK-/- muscles 
(28.6 ± 4.6 µmol~P, n = 7); [t(12) = 0.8420, P = .208, R2 = .056].  
   70 
 
Figure XXI. SkMLCK expression does not augment total energy turnover (A, P = .448) or activation 
energy turnover (B, P = .208) during 15 s of repetitive low-frequency stimulation. Values are means ± 
SEM, n = 7 contralateral pairs.   
5.4.3.3. Correction for Residual Force Production 
To more accurately partition total energy consumption into contractile and 
activation energy components, the directly measured HEPC values were corrected for 
residual force production during the BTS incubation using the following formula (Zhang 
et al., 2006): 
 𝐸!"!"##!"#!$ = 𝐸!"#$% − 𝐸!𝐸!"#$% 100%%  𝐹𝑜𝑟𝑐𝑒  𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 100%  
Equation XXIV. Correcting for residual force production during myosin inhibition. 
 
Once the percentages of contractile and activation components of energy 
consumption were obtained (Table VII), new corrected HEPC values for crossbridge and 
activation energy components were calculated and compared (Figure XXII).   
  
Table VII. Total energy consumption partitioned into Crossbridge and Activation components. 
 ETotal Raw EA Inhibition EXB EA 
 (µmol~P) (µmol~P) (%) (%) (%) 
Wildtype 47.1 ± 6.9 33.5 ± 3.6 88.2 ± 1.8 32.7 67.3 
skMLCK-/- 48.1 ± 3.1 28.6 ± 4.6 90.4 ± 0.8 44.9 55.1 
Values are means  ± SEM, n = 7. ETotal, total energy consumption; EA activation energy turnover; EXB , crossbridge 
energy consumption.  
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Figure XXII. Total high-energy phosphate consumption (ETotal), partitioned into crossbridge energy 
consumption (EXB) and activation energy turnover (EA). Values have been corrected for residual force 
production during myosin II ATPase inhibition via BTS. Open bars, skMLCK-/-; Closed bars, Wildtype. 
Values expressed as means ± SEM, n = 7 contralateral pairs.  * indicates P < .05 for one-tailed unpaired t-
test. 
 
Mean total high-energy phosphate consumption of skMLCK (48.10 ± 3.10 
µmol~P) and Wildtype (47.10 ± 6.90 µmol~P) were similar [t(12) = 0.132, P = .449, r2 = 
.001], and mean activation energy turnover between skMLCK (26.52 ± 1.71 µmol~P) and 
Wildtype (31.68 ± 4.64 µmol~P) were also similar [t(12) = 1.04, P = .159, r2 = .083]. 
However, the contractile component of energy consumption was significantly larger for 
skMLCK-/- muscles (21.57 ± 1.39 µmol~P) than for Wildtype muscles (15.42 ± 2.26 
µmol~P) [t(12) = 2.32, P = .019, r2 = .310].  
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5.5. Contractile Economy 
It was hypothesized that Wildtype muscles would be more economical than 
skMLCK-/- during the 15 s low-frequency potentiating stimulation. Results of the one-
tailed unpaired t-test with Welch’s correction indicated that Wildtype muscles (3.8 ± 0.8 
mNs/mol~P, n = 7) had higher economy than skMLCK-/- muscles (2.2 ± 0.2 mNs/mol~P, 
n = 7); [t(6.80) = 2.01, P = .043, r2 = .372]. 
 
 
Figure XXIII. SkMLCK-mediated RLC phosphorylation increases contractile economy of isolated 
mouse EDL during repetitive isometric contraction at 25°C. Values expressed as means ± SEM.  * indicates 
P < .05 for unpaired t-test with Welch’s correction.    
   73 
6. Discussion 
6.1. General Summary 
The present study investigated the effects of RLC phosphorylation-mediated force 
potentiation on the energetics of repetitive isometric activation of isolated fast twitch 
skeletal muscle. This study is the first to directly examine the effects of RLC 
phosphorylation on muscle energetics and contractile economy by using skMLCK-/- mice: 
a negative control generated through gene ablation. This study is also the first to use BTS 
to partition energy consumption into contractile and non-contractile components in this 
genetic model. Results indicated that (i) RLC phosphorylation did not impact total energy 
consumption or activation energy turnover, but decreased the crossbridge component of 
energy consumption (ii) RLC phosphorylation augmented peak twitch force and total 
isometric work production (iii) RLC phosphorylation significantly increased contractile 
economy. 
6.2. Myosin RLC Phosphorylation 
At rest, average fractional RLC phosphate content of Wildtype muscle was double 
that of skMLCK-/- muscle; values that are both in agreement with previously published 
resting values (e.g. Crow & Kushmerick, 1982b; Zhi et al., 2005). It is interesting to note 
that although skMLCK-/- muscles do not contain the enzymatic machinery responsible for 
RLC phosphorylation, a small fraction of RLCs appear to be phosphorylated. This 
phenomenon was originally noted by Zhi et al. (2005) when a monophosphorylated band 
of RLCs appeared after deliberately overexposing their skMLCK-/- blots. Presumably, 
this phosphorylation in the absence of skMLCK is due to a non-specific kinase, which, 
unlike skMLCK, is not stimulation-dependent. Indeed, the potentiating stimulation 
resulted in a 3-fold increase in RLC phosphate content in Wildtype muscle, while no 
change was evident in skMLCK-/- muscle. These data provide further evidence that 
whatever kinase is responsible for the phosphorylation noted in skMLCK-/- muscle, it is 
not activated by elevations of myoplasmic [Ca2+]. 
Following the potentiating stimulus, Wildtype RLC phosphate content was 36%. 
While this number is lower than previous values reported from our lab and others (often 
>50%, see Vandenboom et al., 2013 for a review), this is most likely due to the particular 
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experimental design adopted for this study. Sequential activation of skMLCK during 
electrical stimulation leads to RLC phosphorylation, and even after the muscle has 
relaxed, the kinase remains active for a period of time (Stull et al., 2011). It had become 
commonplace to freeze muscles for analysis ~10-15 s after a potentiating stimulus, 
allowing skMLCK to continue its enzymatic activity, enabling researchers to catch the 
peak RLC phosphorylation (e.g. Caterini, Gittings, Huang, & Vandenboom, 2011; 
Gittings, Huang, & Vandenboom, 2012; Zhi et al., 2005).  Since the present study ran 
parallel experiments to measure changes in metabolites, it was imperative that muscles be 
frozen immediately following the final pulse of the potentiating stimulus to prevent any 
further ATP breakdown or replenishment, negating the time required for peak 
phosphorylation to occur. 
6.2.1. Comment on BTS Specificity 
The original pharmacological inhibitor of fast muscle myosin, 2,3-butanedione 
monoxime (BDM), eventually experienced a loss of prominence due to its lack of 
specificity. It was discovered that BDM alters Ca2+ release, and, extremely relevant to the 
present study, significantly decreases myosin RLC phosphorylation (Siegman et al., 
1994). BDM’s successor, N-benzyl-p-toluene sulfonamide (BTS), is now the preferred 
pharmacological inhibitor of the myosin II ATPase used in energy partitioning 
experiments. Although several previous studies have investigated BTS specificity using 
purified enzymes, potential non-specific effects are always a cause for a concern when 
using intact muscle models. Work using single intact fibres, as well as intact fibre 
bundles, demonstrated that BTS does not affect intracellular calcium transients (Bruton, 
Pinniger, Lännergren, & Westerblad, 2006; Pinniger, Bruton, Westerblad, & Ranatunga, 
2005), making it ideal for determining activation energy turnover. A novel finding of our 
study is that an 80 min incubation in 25 µm BTS did not impact skMLCK or its 
phosphorylation of the myosin RLC, providing further evidence of the highly specific 
nature of this small-molecule myosin II ATPase inhibitor. 
   75 
6.3. Contractile Performance of Wildtype and skMLCK-/- Muscles 
6.3.1. Staircase Potentiation of Force 
Muscles from control Wildtype and skMLCK-/- mice were similar in mass, and 
PCSA, and unsurprisingly, their initial contractile characteristics were very similar. The 
higher resting RLC phosphate content of Wildtype muscle compared to skMLCK-/- 
muscle was not sufficient to augment Wildtype force output, as there were no differences 
in initial twitch force. The Ca2+ released during repetitive stimulation activated skMLCK, 
increasing fractional activation of skMLCK as stimulation continued due to the slow 
dissociation of Ca2+4-CaM from the enzyme complex (Stull et al., 2011). By the end of 
the 15 s potentiating stimulus, progressive RLC phosphorylation resulted in step-like 
increases in twitch force, culminating with a ~25% increase Wildtype muscle twitch 
force. Consistent with previous reports of divergent potentiation mechanisms (Gittings et 
al., 2011; Zhi et al., 2005), a ~5% increase in skMLCK-/- muscle twitch force was noted; 
however, as expected, the staircase potentiation of twitch force was significantly 
dampened in the skMLCK-/- muscles.  
The phenomenon of RLC phosphorylation-independent force potentiation has 
been studied previously using lumbrical muscles (Smith et al., 2013). These unique fast 
twitch muscles have an unbalanced expression between skMLCK and skMLCP, thus 
displaying no detectable RLC phosphorylation at rest or after stimulation. The observed 
potentiation in the absence of RLC phosphorylation was attributed to an elevation in 
resting myoplasmic Ca2+ concentration ([Ca2+]resting) that resulted from tetanic stimulation 
(Smith et al., 2013), and more recent work has shown repetitive low-frequency 
stimulation produces an analogous effect (Smith, Vandenboom, & Tupling, 2014). This 
elevated [Ca2+]resting effectively increases the Ca2+-sensitivity of the contractile apparatus, 
either by increasing Ca2+ occupancy of TnC at rest, or by saturating Ca2+ buffering 
systems, thereby reducing the competition for Ca2+ occupancy of TnC (Smith et al., 
2013). This effect occurs in both skMLCK-/- and Wildtype muscles; thus, the potentiating 
effect of skMLCK-mediated RLC phosphorylation can be parsed out by simply observing 
the disparities in force output between skMLCK-/- (i.e. increased [Ca2+]resting) and 
Wildtype muscles (i.e. increased [Ca2+]resting in conjunction with RLC phosphorylation).  
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Although the 36% phosphorylation measured in the current study is on the lower 
end of previously reported values (see Vandenboom et al., 2013), contractile performance 
of Wildtype muscle was still augmented. The potentiating stimulation used allowed the 
Wildtype muscles to reach a near-optimal state of potentiation, where superior 
mechanical output is produced resulting from the counteracting effects of fatigue and 
potentiation. It has been documented that skMLCK gene ablation, and subsequent 
inhibition of RLC phosphorylation, exacerbates the reduction of low–frequency force 
seen in moderately fatigued skeletal muscle (Gittings et al., 2011). When examining the 
force traces in Figure XIV, an initial decrease in force production is apparent in 
skMLCK-/- muscles, while this effect is less severe in Wildtype muscles. Force 
production remains below baseline values in skMLCK-/- muscles for a period of time, yet 
force output from Wildtype muscles begins to steadily climb, in a classic demonstration 
of staircase potentiation.  
The force response to repetitive low-frequency stimulation is essentially the result 
of the balance between mechanisms of force enhancement and force diminishment. As 
discussed in the literature review, the force of isometric contraction (Equation II) is 
primarily a function of the number of crossbridges that are engaged simultaneously in the 
strongly bound state. This is governed by Ca2+ occupancy of TnC, as well as the rate 
constants for the transition to the strongly bound state, and dissociation of crossbridge 
binding. Assuming that identical stimulation paradigms led to similar Ca2+ release 
between genotypes, there would be no differences in Ca2+ occupancy of TnC, nor the rate 
of crossbridge dissociation (which remains constant). Thus, RLC phosphorylation 
increases the rate constant for transition into strongly bound states in Wildtype muscle, 
increasing the rate of force development (Equation III) and peak force. During the 
repetitive stimulation, an elevation [Ca2+]resting increases the Ca2+-sensitivity of the 
contractile apparatus; an effect that is additive with RLC phosphorylation (Smith et al., 
2013); however, Ca2+-dependent inactivation of Ca2+ release from the SR has also been 
observed during closely spaced contractions (Barclay, 2012). In fact, the same Ca2+4-
CaM complex that activates skMLCK is also able to induce inhibition of the RyR Ca2+ 
release channel, reducing the quanta of Ca2+ released during stimulation (Jones, Squier, 
Boschek, & Bigelow, 2007; Xiong, Zhang, He, & Hamilton, 2006). Wildtype muscle 
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simultaneously decreases the release of Ca2+ while preserving its contractile function 
through increasing Ca2+-sensitivity. This effect is negated in skMLCK-/- muscle with 
depressed Ca2+ release and no compensatory mechanism. Even though Ca2+-dependent 
inactivation of Ca2+ release occurs, recent work has shown a prolongation of the 
intracellular Ca2+ transient (ICT) during staircase potentiation in lumbrical muscle (Smith 
et al., 2014). Interestingly, the duration of the ICT appears to be more important than the 
amplitude for twitch force development. It was suggested that the lingering ICT could be 
due to accumulation of metabolic byproducts such as ADP and/or Pi that slow the Ca2+-
pumping activities of SERCA, and would accordingly be expected to prolong ICT decay 
times (Smith et al., 2014). Since equivalent quantities of high-energy phosphates were 
consumed by Wildtype and skMLCK-/- muscles, there would have been comparable 
accumulation of metabolic byproducts, and thus similar effects of fatigue; however, the 
effects of fatigue are masked by RLC phosphorylation in Wildtype muscle, and the 
improved contractile performance for which it is responsible. It is clear that the 
mechanisms of force enhancement outweigh those of force diminishment in Wildtype 
skeletal muscle, while the opposite is true in the absence of skMLCK.  
6.3.2. Inhibition of Force Production 
Previous energy partitioning studies employing BTS as a pharmacological 
inhibitor of myosin used incubation periods ranging from 30 min (Barclay, 2012) or 45 
min (Barclay et al., 2008) for fibre bundles, to 60 min (Zhang et al., 2006) when using 
whole muscle preparations. Our study used a longer BTS incubation period, as pilot work 
revealed that 80 min was necessary for 25 µm BTS to inhibit nearly all (~94%) of twitch 
force production. Muscle viability during this incubation was not an issue, as the muscle 
was virtually quiescent, apart from a single twitch elicited at 5 min intervals to track 
inhibition of force. It is interesting to note, that while BTS was able to inhibit the vast 
majority of force production, there was still a significant potentiation of the remnant force 
during the potentiating stimulus (data not shown).  
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6.3.3. Potentiation of the Force-Time Integral 
Expression of skMLCK, and the subsequent RLC phosphorylation for which it is 
responsible, resulted in an average total FTI (i.e. isometric work) that was 44% larger 
than the average FTI produced by muscles devoid of this enzyme. The ability of RLC 
phosphorylation to potentiate force and work is well documented (Caterini et al., 2011; 
Gittings et al., 2012; Gittings, Aggarwal, Stull, & Vandenboom, 2014). While muscles 
from both Wildtype and skMLCK-/- genotypes began the potentiating stimulus with 
similar peak twitch force, time to peak tension (TPT) was significantly longer in 
Wildtype muscles than skMLCK-/-; a trend that continued throughout the duration of the 
stimulus. As the stimulation continued, Ca2+4-CaM activated skMLCK in Wildtype 
muscle, and Wildtype force was potentiated above skMLCK-/- levels. RLC 
phosphorylation was responsible for increased rate of force development (Equation III) 
during the stimulation, and increasing the number of cycling crossbridges in a force 
generating state (Brenner, 1988), allowing Wildtype muscle to produce higher peak 
forces. Furthermore, half-relaxation time (RT1/2) was faster in skMLCK-/- muscles - an 
effect previously documented by Gittings et al. (2011). These changes in kinetics 
beneficially altered the summation of force during the repetitive stimulation: Wildtype 
muscles were unable to relax between successive stimuli as fully as skMLCK-/- muscles, 
ultimately enlarging the area under the force-time trace  (FTI), significantly increasing 
the amount of isometric work performed during the 15 s protocol. 
6.4. Skeletal Muscle Energetics  
Neither myosin II ATPase inhibition or skMLCK expression impacted resting 
concentration of any metabolite that was measured. Following stimulation, Control 
Wildtype and skMLCK-/- groups had larger changes in metabolite concentrations, while 
and their respective BTS groups metabolized less PCr and produced less lactate, as would 
be expected with myosin II ATPase inhibition. At first glance, it appears that Wildtype 
muscles produced larger quantities of lactate, because stimulated Wildtype muscle had a 
significantly higher lactate concentration than the stimulated Wildtype or skMLCK-/- BTS 
groups; however, due to the large degree of variation apparent when change in lactate 
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concentrations were calculated, there were no significant differences in among groups for 
%Δ Lactate. 
6.4.1. Total Energy Consumption (ETotal) 
It was assumed that the augmented contractile output of Wildtype muscles would 
be accompanied by an increase in energy consumption above that of skMLCK-/- muscles; 
however, only a 2% difference in ETotal between Wildtype and skMLCK-/- muscles was 
documented. Similar to Barsotti and Butler (1984) who reported no change in energy 
consumption upon RLC phosphorylation during isometric tetani, we found that an 
increased RLC phosphate content did not affect overall energy turnover during 
submaximal contraction. This apparent lack of effect of myosin phosphorylation upon the 
rate of chemical energy usage in mouse EDL also the corroborates findings of Morgan et 
al. (1976) who demonstrated RLC phosphorylation had little to no effect on the ATPase 
rates of isolated myosin.  
6.4.2. Crossbridge Component of Energy Consumption (EXB) 
It was somewhat unexpected that the crossbridge component of energy 
consumption (EXB) was significantly larger for skMLCK-/- muscles than for Wildtype 
muscles. In fact, the opposite effect was theorized, since Equation IV dictates that myosin 
ATP consumption increases proportionally with RLC phosphorylation-mediated 
increases in the rate of crossbridge transition to force generating state (fapp), and no 
change in gapp (Brenner, 1988; Sweeney & Stull, 1990). This equation is built upon the 
assumption of tight coupling: one molecule of ATP is hydrolyzed per crossbridge cycle. 
If indeed one crossbridge cycle is completed per ATP molecule, then skMLCK-/- muscles 
may have performed more crossbridge cycles during the stimulus period than Wildtype 
muscles - a finding that is consistent with previous literature claiming that there is no 
change in ATPase rates, but a decreased crossbridge cycling rate, when the RLCs are 
phosphorylated (Barsotti & Butler, 1984). During an identical stimulation protocol, the 
myosin ATPases in skMLCK-/- muscle consumed more ATP, yet the Wildtype 
demonstrated clear force potentiation. If Wildtype muscles completed less crossbridge 
cycles, their improved performance must be explained by differences in thermodynamic 
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efficiency, that is the fraction of energy harnessed to perform mechanical work per ATP 
consumed by myosin ATPases.  
Wildtype and skMLCK-/- thermodynamic efficiency (𝜂) was calculated, assuming a ∆𝐺!"# of -60 kJ mol-1 (or 100 zJ per molecule; z is zepto, the metric prefix describing 
10-21) in mammalian skeletal muscle (Barclay, Woledge, & Curtin, 2010a). Ultimately, an 
average Wildtype crossbridge cycle converted 19% of the free energy produced during 
the hydrolysis of ATP into mechanical work, while skMLCK-/- converted only 9%; thus, 
a ~2-fold increase in the maximum work completed per crossbridge cycle (WXB) occurred 
concomitant with RLC phosphorylation.  
 
Recall the thermodynamic efficiency equation (Equation XI): 𝜂 = 𝑊∆𝐺!"# 
 
Wildtype calculations: 𝜂!"#$%&'( = 𝐹𝑇𝐼𝐸!"    ∙   ∆𝐺!"# = 152.7  𝑚𝑁𝑠13.6  𝜇𝑚𝑜𝑙~𝑃   ∙   60  𝑚𝐽 ∙ 𝜇𝑚𝑜𝑙!! = 0.19   
 𝑊!" = 100  𝑧𝐽  𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒!!  ×  0.19 = 19  𝑧𝐽   
 
skMLCK-/- calculations: 𝜂!"#$%!!/! = 𝐹𝑇𝐼𝐸!"    ∙   ∆𝐺!"# = 105.8  𝑚𝑁𝑠19.5  𝜇𝑚𝑜𝑙~𝑃   ∙   60  𝑚𝐽 ∙ 𝜇𝑚𝑜𝑙!! = 0.09   
 𝑊!" = 100  𝑧𝐽  𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒!!  ×  0.09 = 9  𝑧𝐽   
 
These data, and the estimates presented for discussion, indicate that RLC 
phosphorylation may have decreased the crossbridge cycling rate, and increased the 
average work per crossbridge cycle. Sweeney and Stull (1980) purported that RLC 
phosphorylation results in an increased rate at which crossbridges enter the force 
generating state, a finding that is in accordance with our results. However, Sweeney and 
Stull (1980) also believed it unlikely that RLC phosphorylation would affect average 
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force per crossbridge or the rate of detachment, which is a model that contradicts our 
data.  
Results from in vitro motility assays have demonstrated that the covalent 
modification of the RLC causes an alteration to myosin’s function as a molecular strain 
sensor, slowing the strain-dependent ADP release during crossbridge cycling – an effect 
that caused a decreased shortening velocity and an increased myosin duty cycle 
(Greenberg et al., 2009). This same work also suggested a phosphorylation-induced 
stiffening of the lever arm of myosin, capable of more efficiently transmitting 
conformational changes into force, and increasing unitary step-size (Greenberg et al., 
2009). This mechanistic research supports Kerrick, Potter, and Hoar (1991), who 
suggested that the rate of dissociation of force generating crossbridges decreases with 
increased actin-myosin interaction. Increasing thin filament activation may increase the 
myosin duty cycle and the time required for ADP release from myosin’s nucleotide 
pocket; thus, ATP turnover for each crossbridge may be reduced, as a new molecule of 
ATP cannot be hydrolyzed until ADP is released and myosin disassociates from actin. It 
is possible that in Wildtype muscle in our study, RLC phosphorylation was responsible 
for stiffening the lever arms, and altering the biochemistry of myosin. The accompanied 
increase in duty cycle reduced the crossbridge turnover, and the more efficient 
transmission of conformational changes into force increased work per crossbridge, 
resulting in a lower EXB than skMLCK-/- muscle. These transient alterations to the 
contractile apparatus can be reconciled with the Brenner (1988) equations for the fraction 
of crossbridges in the force producing state (Equation I), isometric force (Equation II), 
and isometric ATPase rates (Equation IV) to explain the advantageous consequences of 
RLC phosphorylation.  
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During submaximal stimulation when [Ca2+] is low, and the rate of crossbridge 
detachment (𝑔!"") is far larger than the rate of crossbridges entering the force generating 
state (𝑓!""), any increase in 𝑓!"" causes large increases in the fraction of crossbridges in 
the force generating state (𝛼!") as determined by Equation I: 
 𝜶𝑭𝒔 = 𝒇𝒂𝒑𝒑/(𝒇𝒂𝒑𝒑 + 𝒈𝒂𝒑𝒑) 
 
When 𝑪𝒂𝟐! 𝒊  is low 𝒈𝒂𝒑𝒑 ≫ 𝒇𝒂𝒑𝒑 
 ↑ 𝒇𝒂𝒑𝒑/(↑ 𝒇𝒂𝒑𝒑 +𝒈𝒂𝒑𝒑)   =  ↑ 𝜶𝑭𝒔 
  
If indeed 𝑔!"" decreases during RLC phosphorylation, as we have suggested, 
increases in 𝛼!"  will be larger than if 𝑔!""  had remained constant. Additionally, 
increasing 𝑓!""  while simultaneously decreasing 𝑔!""  may theoretically lower the 
isometric myosin ATP turnover as determined by Equation IV. Considering that the 
number of cycling crossbridges (𝑛) and the number of half sarcomeres in the fibre (𝑏) 
should remain constant, and (𝑓!"" + 𝑔!"") theoretically approaches 𝑔!"" at low [Ca2+], 
the largest and most determinate term in this equation is 𝑔!"".  
 
If: 𝑟! = 𝑛𝑏𝑔!""𝛼!" 
 
Then: 𝑛𝑏 ↓ 𝒈𝒂𝒑𝒑 ↑ 𝛼!" =↓ 𝑟! 
 
Reducing the rate at which crossbridges detach means increasing the time that 
myosin is bound to actin, i.e. increasing the myosin duty cycle, and according to Equation 
IV would cause a reduction in the associated ATP cost of force production, while 
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augmenting isometric force (F), as 𝑔!"" is in the denominator of the term 𝛼!" in Equation 
II for isometric force (𝐹 = 𝑛𝐹𝛼!"). 
It is commonly accepted that the myosin ATPase consumes the majority of energy 
during skeletal muscle contraction; however, our results indicate that during our 15 s 
stimulus, EXB was a relatively small component (33-45%) of ETotal. EDL muscles from 
young mice generally display a twitch:tetanus ratio of 0.23 at the temperature used during 
our study (Brooks & Faulkner, 1988); additionally, peak twitch force has been said to 
represent ~5-20% of the maximum force a muscle can generate (MacIntosh et al., 2012). 
This means that during the 10 Hz stimulation frequency, the EDLs were producing only 
~20% of maximal force. Experiments using chemically skinned frog fibres showed that 
the proportion of EXB relative to total ATP consumption decreases as relative force 
decreases (Stienen, Zaremba, & Elzinga, 1995); thus, at the low activation frequency we 
employed, the EXB is anticipated to be relatively small. A figure from Stienen et al. 
(1995) depicting the Ca2+-dependence of both myosin ATPase and SERCA activity 
illustrates that during maximal force production, activation energy turnover (EA) is ~25% 
while EXB is ~75%. Conversely, during very low levels of activation, such as eliciting 
individual twitches, EA actually accounts for ~55% of energy consumed, while EXB is 
~45%. It appears that EA actually hits a peak and plateaus at ~20% of maximal activation, 
whereas the EXB continually rises until maximal activation is achieved (Stienen et al., 
1995).  
The idea of a plateauing EA is further supported by Tsianos, Rustin, and Loeb 
(2012), who demonstrated EA was constant across a range of shortening speeds, while 
ETotal and EXB were dynamic, both hitting their lowest point during isometric contraction. 
Finally, our study was conducted using a relatively short muscle length, ~0.90 Lo which 
is a length at which the muscle can only produce 70% of the maximal twitch force 
produced at Lo. Inevitably, having the muscle at a length below Lo reduces actin-myosin 
interaction and reduces the associated EXB relative to Etotal. Thus, it is not unreasonable to 
have a low percentage of EXB given the experimental variables adopted by this study.  
   84 
6.4.3. Activation Energy Turnover (EA) 
We expected that Wildtype muscles would have a higher activation energy 
turnover (EA) than skMLCK-/-, initially hypothesizing that the energetic overhead of 
myosin RLC phosphorylation may be inflating this non-contractile component of energy 
consumption. While Wildtype muscle did have a ~19% higher EA, this difference failed 
to reach statistical significance, possibly due to the inherent variability involved in 
biochemical analysis of metabolites. Since BTS incubation did not affect the shape of the 
ICT, calcium handling, or its associated energy cost (Bruton et al., 2006; Pinniger et al., 
2005), it is plausible that the larger EA of Wildtype muscle is related to the cost of 
stimulation-induced elevations of RLC phosphorylation. The absolute difference in EA 
between Wildtype and skMLCK-/- muscles was ~5 µmol~P, which equates to ~10% of the 
total energy consumed by Wildtype muscles. While Homsher (1987) claimed that the 
ATP consumed for RLC phosphorylation may be equivalent to 5% of the energy used 
during a 5 s tetanus (at 0°C), our study (at 25°C) did not employ tetanic stimulation, and 
thus the ETotal is much smaller, ultimately increasing the percentage of ETotal that can 
possibly be attributed to skMLCK-mediated RLC phosphorylation. 
After correcting for residual force development during BTS incubation, EA 
accounted for ~68% of ETotal for Wildtype, and ~55% for skMLCK-/-. While these 
numbers fall on the higher end of the spectrum of previously reported values from 
isolated mouse EDL (Table VIII), they are not unreasonable.  Many initial studies that 
reported ~33% EA in various animal models have conducted experiments at much lower 
temperatures (see Barclay et al., 2007 for a review). Temperature-dependent increases in 
SERCA activity have been reported in chemically skinned amphibian muscle fibres, with 
SERCA ATP consumption jumping from ~28% of total ATP consumption at 5°C, to 48% 
of total ATP consumption at 20°C (Stienen et al., 1995). Additionally, an earlier study 
estimated that SERCA activity accounts for 56% of total energy liberation at 20°C (Rall, 
1982). Thus, using a temperature of 25°C in the current study may explain the larger 
percentage of ETotal that is accounted for by only activation processes.  
Interesting work conducted using human muscle revealed different ATPase 
activity in various fast muscle fibre types, leading to different energy consumptions for 
both contractile and non-contractile processes (Szentesi, Zaremba, Mechelen, & Stienen, 
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2001). In IIA/B and IIB fibres, SERCA activity is higher than myosin ATPase activity, 
and only in IIA fibres is the myosin ATPase activity higher than SERCA (Szentesi et al., 
2001). As discussed previously, mouse EDL is mostly predominately IIX and IIB, with 
only a small percentage of IIA fibres; thus, it stands to reason that a muscle of this fibre 
composition would have a higher SERCA activity relative to myosin ATPase rates, 
leading to a larger EA than reported in other models (amphibian, fish, mammalian soleus, 
etc.).   
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Table VIII. Previously reported activation energy turnover of mouse EDL. 
Authors 
(Year) 
EA 
(%) 
T 
(°C) 
Stimulation 
Paradigm 
Myosin  
Inhibition 
Energy 
Measurement 
Wendt & Barclay (1980) 33 27 100 Hz, 0.5 s Pre-Stretch 
Total heat 
production 
Barsotti & Butler (1984) 37 23 66 Hz, 1 s Pre-Stretch 
Chemical 
analysis 
 46 23 66 Hz, 7 s Pre-Stretch 
Chemical 
analysis 
Siegman et al. (1994) 61 20 66 Hz, 7 s BDM 
Chemical 
analysis 
Barclay (1996) 35 25 125 Hz, 0.2 s Pre-Stretch 
Initial heat 
production 
Zhang et al. (2006) 47 15 50 Hz, 2 s BTS 
Chemical 
analysis 
 76 30 50 Hz, 2 s BTS 
Chemical 
analysis 
 81 30 50 Hz, 5 s BTS 
Chemical 
analysis 
 82 30 50 Hz, 10 s BTS 
Chemical 
analysis 
Barclay et al. (2008) 36 20 100 Hz, 1 s Pre-Stretch 
Total heat 
production 
 31 30 140 Hz, 1 s Pre-Stretch 
Total heat 
production 
 46 20 100 Hz, 1 s BTS 
Total heat 
production 
 38 30 140 Hz, 1 s BTS 
Total heat 
production 
 34 20 15 Hz, 1 s BTS 
Total heat 
production 
 32 30 15 Hz, 1 s BTS 
Total heat 
production 
Current Study 67 25 10 Hz, 15 s BTS 
Chemical 
analysis 
 55 25 10 Hz, 15 s BTS 
Chemical 
analysis 
EA, activation energy turnover; T, temperature; Pre-stretch, crossbridge cycling inhibited progressively 
longer sarcomere lengths to decrease actin and myosin interaction creating a curve and extrapolating to 
zero; BDM, 2,3-butanedione monoxime; BTS, N-benzyl-p-toluene sulfonamide; Total heat production, heat 
arising in response to contraction (equivalent to O2 consumption), with energy turnover estimated via 
enthalpy (work + heat); Initial heat production, heat produced only with the time course of contraction, with 
energy turnover estimated via enthalpy (work + heat); Chemical analysis, energy turnover calculated using 
changes in metabolite concentrations measured by either spectrofluorimetry or HPLC.  
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Previous experiments (Table VIII), conducted at temperatures between 15-30°C, 
using various methods, measured EA values that range between 31% and 82%; a range in 
which the results from the present study fall. Several studies conducted using 
pharmacological myosin II ATPase inhibition via BDM or BTS, and measuring energy 
turnover using chemical analysis (Siegman et al., 1994; S. J. Zhang et al., 2006), 
produced EA values that most closely resemble the results of our study. While these 
values are in accordance with one another, they are higher than values produced from 
studies using pre-stretch methods and enthalpy measurements. This is very thought-
provoking, since Barclay et al. (2008) found the pre-stretch method and pharmacological 
inhibition by BTS to produce equivalent results. Barclay and colleagues generally use 
EDL fibre bundles, whereas the studies producing higher EA values, including the present 
one, used whole muscle preparations. It is possible that BTS is better able to diffuse into 
all muscle cells of the fibre bundle while failing to reach the deepest muscle cells in 
whole muscle preparations. This would lead to differences in myosin II ATPase 
inhibition, artificially inflating EA in whole muscle studies. It is also worth noting that 
Barclay and colleagues estimate energy consumption by measuring heat production and 
work to calculate enthalpy, where as our study and others (e.g. Siegman et al., 1994; S. J. 
Zhang et al., 2006) snap-froze muscles before and after stimulation to quantify extracted 
metabolites. The inherent error propagation involved in calculating high-energy 
phosphate consumption from changes in metabolites may also play a role in large range 
of EA values in the literature, and explain why values from different methods diverge.   
Barclay and colleagues have also used brief stimulation durations (e.g. 0.2-1 s) 
while studies with results that more closely agree with our own have used relatively 
longer durations (e.g. 2-15 s). This may be an explanation for the different EA values, as 
earlier studies have indicated that the percent contribution of EXB to ETotal decreases as 
contraction duration is prolonged in mouse EDL (Crow & Kushmerick, 1982a), an effect 
that would cause a proportional increase in EA. It is quite possible that the reported 
decrease in EXB that manifested as stimulus duration increased was in part due to RLC 
phosphorylation. Barclay and colleagues’ work, using brief stimulation, would not give 
sufficient time for RLC phosphorylation to occur; thus, the main phenomenon being 
investigated in our research would not be a factor capable of impacting their results.  
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Those who have measured the highest EA of ~80% suggested that the submaximal 
activation utilized may have resulted in the large value (Zhang et al., 2006). This has 
become a point of contention (see Barclay et al., 2007), and previous work remains 
inconclusive as to the effect of activation level on EA. Some researchers claim that 
lowering activation level increases EA; and indeed, reducing activation from maximal to 
1/3 resulted in a ~10% increase in EA (Wendt & Barclay, 1980). Alternatively, others 
found that while myosin was inhibited via BDM, decreasing stimulation frequency either 
decreased or did not change EA in Type II fibres, and it increased in Type I fibres 
(Buschman, Van der Laarse, Stienen, & Elzinga, 1996). It makes mathematical sense that 
EA is increased in relation to ETotal when activation level decreases, since, as discussed in 
6.4.2., EA plateaus and remains constant across many activation frequencies and 
velocities, while ETotal and EXB increase with increasing activation level and velocity. 
Overall, our results lend support to several previous findings that ion pumping accounts 
for a large majority of energy consumed during submaximal isometric contraction in 
mouse fast muscle.  
6.5. Contractile Economy 
Wildtype muscle with an intact RLC phosphorylation mechanism had a far higher 
contractile economy than muscle devoid of skMLCK. Since ETotal was very similar 
between genotypes, the increase in contractile performance and work per crossbridge 
cycle due to myosin RLC phosphorylation is responsible for boosting economy by 73% 
during 15 s of submaximal isometric activation. The efficiency (i.e. work/enthalpy) of 
fast twitch mouse EDL has been reported to fall between 0.29 – 0.33 (Barclay, 1996; 
Barclay et al., 1993), meaning that approximately 30% of the total energy consumed is 
converted to work. In the present study, Wildtype muscles and skMLCK-/- muscles had 
contractile economies (i.e. work/HEPC) of 0.38 and 0.22, respectively. Although 
efficiency and economy are measured differently, they attempt to answer a similar 
question, and our values seem comparable and acceptable. It is evident that skMLCK and 
RLC phosphorylation may play a major role in the ratio of force produced to energy 
consumed during contraction.  
 Initially, Barsotti & Butler (1984) reported that mouse EDL showed a reduction in 
average rate of energy consumption when myosin RLCs were phosphorylated; an effect 
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that was dependent upon both stimulation duration and history. After further 
experimentation, they were unable to find a consistent relationship between RLC 
phosphorylation and the energy consumption. Crow & Kushmerick (1982b) reported a 
correlation between a myosin RLC phosphorylation and reduced energy cost for 
isometric tetani in mouse fast twitch muscle.  Although this current study did not use 
tetani, we saw that during low-frequency repetitive isometric activation, muscles capable 
of RLC phosphorylation showed a reduced energy cost for force production, supporting 
the relationship between RLC phosphorylation and a reduced cost of contraction. 
Considering that EA was similar between genotypes, the economical difference is clearly 
a reflection of the average work performed during each crossbridge cycle.  
Alternatively, our findings are in stark contrast to Abbate et al. (2001), who 
reported that RLC phosphorylation-mediated force potentiation increased the energetic 
cost of contraction to a higher extent than it increased work output. It was even suggested 
that, in the potentiated state, efficiency of the crossbridges may be compromised, 
reducing mechanical output for each ATP hydrolyzed and negatively impacting the 
economy of the working muscle. That idea opposes our findings, and seems 
counterintuitive. Brown and Loeb (1998) put forth the idea of potentiation being the 
normal operating state of muscle, and Tsianos and Loeb (2014) have described how 
muscles in the unpotentiated state exhibit “odd behavior” in their recent skeletal muscle 
modeling paper. For this reason, all of their modeling equations for fast twitch muscles 
capture their behavior in the fully potentiated state (Tsianos & Loeb, 2014). Moreover, 
skeletal muscles appear less economical during low levels of thin filament activation, 
possibly due to less work per crossbridge cycle (Lewis & Barclay, 2014); thus, 
heightening the Ca2+-sensitivity of the contractile apparatus could have a beneficial effect 
on economy, analogous to, but in the absence of, further increases in [Ca2+] activation. 
Indeed, our findings indicated that the potentiated Wildtype muscle actually had a lower 
EXB, and what appears to be an increased mechanical output for each ATP hydrolyzed. 
However, comparison directly to findings from Abbate et al. (2001) is problematic: the 
vastly different findings may be attributed to the dissimilar models used between studies,  
as they studied this phenomenon in rat EDL, in situ.  
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7. Conclusions & Significance 
7.1. Major Findings 
The present study provided evidence that RLC phosphorylation-mediated force 
potentiation improves the contractile economy of fast twitch mammalian muscle during 
repetitive isometric activation. SkMLCK-mediated phosphorylation of the myosin RLCs 
augmented the relationship between mechanical output and metabolic input by radically 
improving the contractile performance of muscle, without any associated increase in 
energetic cost. Our study demonstrates that during repetitive low-frequency activation, 
ion pumping and other non-contractile processes account for the majority of energy 
consumed. Additionally, it appears that the energetic overhead required to phosphorylate 
the myosin RLCs is insignificant compared to the overall energy cost of continued 
contraction.  
7.2. Significance 
Previous research investigating the effect of RLC phosphorylation on contractile 
economy has been unable to reach a definitive answer. The use of skMLCK-/- mice as a 
robust negative control was a novel aspect of this study, which allowed us to say with 
certainty that economy is improved in the presence of skMLCK. These findings provide 
further evidence of a teleological role of skMLCK in vivo, as a mechanism that can 
enhance contractile performance without further energetic cost. RLC phosphorylation by 
skMLCK appears to be a perfect modulatory mechanism, since it has a profound effect on 
performance, but itself does not consume a considerable amount of energy. While the 
activation cascade responsible for RLC phosphorylation and dephosphorylation are far 
too slow to be an obligatory mechanism for contraction, the continued expression of the 
components necessary for reversible myosin RLC phosphorylation seem to be ultimately 
related to enhanced contractile performance and thermodynamic efficiency at the level of 
the crossbridge.   
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7.3. Future Considerations 
As with most in vitro experiments, these findings are undoubtedly paradigm-
dependent; thus, future work must be aimed at determining the relationship between RLC 
phosphorylation, force potentiation, and the energetic cost of contraction in protocols that 
include concentric and eccentric contractions, as well as span a range of activation 
frequencies. While we were unable to conclusively quantify the energetic overhead of 
myosin RLC phosphorylation, there did appear to be a trend in increasing EA for 
Wildtype muscle. Future work should be conducted using the skMLCK-/- model in 
laboratories equipped to perform higher resolution measurements such as HPLC, 31P-
NMR, or even enthalpy measurements. Perhaps a collaborative venture between labs is 
on the horizon.  
The EDL muscle is an ideal model for studying RLC phosphorylation-mediated 
force potentiation due to composition of fast fibres that contain the necessary enzymatic 
machinery. However, this in vitro model is highly mechanistic, and future work 
investigating the effects of skMLCK on contractile economy should eventually be 
focused on whole body, in vivo studies. It would be interesting to compare whole body 
VO2 of exercising Wildtype and skMLCK-/- mice, to determine whether the increased 
economy in solely fast twitch muscles carries over to a situation in which many muscles 
of mixed fibre types are concurrently activated.  
7.4. Assumptions 
In energy balance experiments measuring high-energy phosphate consumption 
(HEPC) during a brief bout of activity (<30 s), the contribution to overall ATP 
production by oxidative metabolism is no more than 9% (Westra, De Haan, Van Doorn, 
& De Haan, 1988). Even if oxygen delivery is interrupted, the muscle still has access to 
stores of oxygenated hemoglobin and myoglobin that can be used to oxidize pyruvate. To 
circumvent this issue, sodium cyanide (NaCN) is commonly introduced to the 
physiological solution in which the muscle preparation is bathed, as it is able to inhibit 
mitochondrial oxidative phosphorylation at mM concentrations (Barsotti & Butler, 1984). 
Many studies using NaCN elicit tetanic contractions, with no adverse affects on 
contractile activity reported; however, the addition of NaCN resulted in potentiation of 
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directly elicited twitch force, followed by a progressive depression of force (Adler, 
Lebeda, Kauffman, & Deshpande, 1999). Since our study elicited repetitive isometric 
twitches, and the force record is of utmost importance, NaCN was not used to abolish 
oxidative metabolism. This decision was made in an attempt to reduce confounding 
variables impacting the contractile data. Thus, for all metabolite calculations, it is 
assumed that the muscle preparation relies solely on anaerobic substrate-level 
phosphorylation during the brief contractile bout. In addition, HEPC is calculated using 
an equation with the following inherent assumptions: (i) glycogen is the sole source for 
lactate production during contraction, and (ii) any decrease in ATP within the muscle is 
associated with a stoichiometric increase in IMP (Zhang et al., 2006). 
It is also assumed that using BTS selectively inhibits myosin II ATPase, in turn 
depressing force production, while not affecting any other energy consuming processes. It 
has previously been demonstrated that Ca2+ handling is unaffected by BTS in mammalian 
muscle (Pinniger et al., 2005) and pilot experiments revealed that myosin RLC 
phosphorylation is unaffected by BTS incubation. 
7.5. Limitations 
While the in vitro EDL model has become commonplace in this area of research, 
this model is only an approximation of what may be happening while the muscle is active 
in vivo. In vitro, the muscle is submerged in an oxygenated organ bath, recreating the 
osmolality and oxygen supply of in vivo conditions; however, this involves replacing 
circulating blood with Tyrode’s solution, replacing neural control with electrical field 
stimulation, and bathing the muscle at sub-physiological temperatures to maintain 
viability. Obviously, temperature and other environmental variables greatly impact 
enzymatic function; thus, data from this study is strictly mechanistic in nature, and should 
eventually be replicated in an in vivo or in situ model.  
One of the major limitations of rapid freezing followed by chemical analysis of 
extracts of the frozen muscle is the logistical dilemma that arises: each muscle 
preparation provides only a single measurement, at a single time point. Correspondingly, 
it is impossible to adopt a repeated measures design to minimize effects of inter-muscle 
variability, and both HEPC and phosphorylation data must be determined from multiple 
independent measurements.  
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Finally, this study is open to the inherent uncertainty in biochemical 
measurements, which is large compared to the magnitude of changes in concentration of 
the metabolites of interest, particularly when the extent of chemical breakdown is reduced 
due to inhibition of crossbridge cycling. Additionally, any errors in measurements are 
propagated through calculations of HEPC (Equation XXII). Protocols using long tetani or 
repeated brief contractions increase PCr breakdown and reduce relative uncertainty in its 
measurement, which is why a 15 s stimulation protocol was utilized in this project.
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8. Appendix I: 
Preliminary Procedures for Contractile Experiments 
Setting Up the In Vitro Apparatus 
1. After turning on the computer, open the single channel data collection program 
(Linux systems only require a single click, as opposed to the Windows or Mac OS 
X double-click) 
2. Open ‘Set Up’, ‘Protocol’ and ‘Scope’ windows 
3. Switch ASI stimulator and servomotor/force transducer control units ON 
4. Zero the force in signal by clicking ‘Record Fin’ in ‘Set Up’ window periodically 
until the value stabilizes around a given number (usually 27-32 mV) - servomotor 
arm needs voltage to stabilize in resting position 
5. Turn Circulator ON – compressor should stay ON, set to LOW 
6. Pack ice around auxiliary organ bath if necessary 
7. Insert closed needle valve into vertical jacketed organ bath 
8. Pour fresh Tyrode’s solution into both baths 
9. Open master value on mixed gas cylinder, followed by secondary black valve 
located on the regulator 
10. Open cut off valves on tubing that feed the organ baths required for the 
experiment 
11. Fine tune the oxygen flow to each bath with fine black adjustment knobs on the 
gas dispersal units to obtain a steady stream of bubbles 
12. Turn tank off until experiment begins to conserve oxygen 
 
Surgical Procedures 
1. Dilute stock sodium pentobarbital to working concentration 
2. Weigh mouse and calculate anesthetic dose required 
3. Administer the IP injection 
4. Begin procedures once the pedal reflex is absent 
5. Remove skin to expose hind limb musculature 
6. Pin foot down 
7. Remove fascia from TA and relieve tendons held under the tensor ligament 
8. Isolate TA tendon, and remove TA 
9. Stop bleeding associated with rupture of TA blood supply using Tyrode’s soaked 
gauze 
10. Tie non-absorbable silk sutures to the proximal and distal tendons of the EDL 
11. Cut tendons and mount muscle 
 
Mounting Isolated Muscles 
1. Zero Fin 
2. Open bottom clamp 
3. Loop top suture onto servomotor lever arm 
4. Straighten bottom suture and insert into bottom clamp  
   106 
5. Tighten bottom clamp 
6. Adjust muscle length with coarse adjustment knob until just taut length is reached 
7. Tighten white screw behind apparatus to lock in place 
8. Use fine adjustment knob to obtain 3-5 mN resting tension. 
9. Measure muscle length using digital vernier calipers  
10. Input value as ‘Reference Length’ in Set Up window, hit Enter, then record Lin 
11. Check boxes for Lo=Lref and Lf=Lo 
12. Click ‘Verify Sequence’, and ‘Save' 
13. Flip stimulator to Gated Trigger Mode (from Follow) 
14. Leave voltage knob as maximal, and adjust the current to achieve maximal twitch 
force through manual triggering (usually around 7-8 mA) 
 
Equilibration and Determining Lo 
1. Load equilibration sequence in Sequencer view of Protocol window 
2. Enable Slip Tetanus and Equilibration protocols 
3. Manually stimulate muscle at various lengths to determine Lo - from 0 mN to 20 
mN resting tension is a good range 
4. Allow muscle to rest ~30 s between twitches  
5. Determine the resting tension at which the largest active force is produced (i.e. 
total tension – passive tension) 
6. Set muscle length to resting tension that best represents Lo, and if there are 2 
similar results then pick the lower value 
7. Use digital vernier calipers to measure the new length, input as Reference Length 
and record Lin  
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9. Appendix II: 
Measurement of Myosin Regulatory Light Chain Phosphorylation 
by Urea/Glycerol-PAGE with Immunoblotting 
 
Myosin regulatory light chains (RLCs) are small (18− 20  𝑘𝐷𝑎) acidic (pI about 
4.8 with net charge of -18) proteins that migrate easily in polyacrylamide gels containing 
glycerol for density. RLCs are denatured with trichloroacetic acid (TCA) and solubilized 
in urea to dissociate the RLCs from the myosin heavy chains. The addition of a single 
phosphate introduces two additional negative charges at pH 8.6 (the pH of the running 
buffer) so the phosphorylated protein migrates faster than the non-phosphorylated RLC. 
Thus, the phosphorylation measurements are quantitative (mol per mol), not relative 
(degree of change) after measurements of the protein band density by immunoblotting. 
 
Sample Preparation 
Prepare Stock Solutions 
Acetone-Based Protein Precipitation Solution (5 mL) 
10% Trichloroacetic acid (TCA), 10 mM DTT in ice-cold acetone (-20 C) 
TCA (T8657) 0.5 g 
DTT (D0632) 7.71 mg 
Acetone 2.5 mL 
Dissolve  
Acetone Q.S. to 5 mL 
N.B. Make fresh on day of sample preparation, and store in -20 C until use. 
 
Water-Based Protein Precipitation Solution (5 mL) 
10% Trichloroacetic acid (TCA), 10 mM DTT in  
TCA (T8657) 0.5 g 
DTT (D0632) 7.71 mg 
dH2O 2.5 mL 
Dissolve  
dH2O Q.S. to 5 mL 
N.B. Make fresh on day of sample preparation, and store in -20 C until use. 
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Prepare Buffers 
Gel Buffer (500 mL) 
Trizma base 13.7 g 
Glycine 10.0 g 
dH2O 250 mL 
Dissolve  
dH2O Q.S. to 500 mL 
N.B. Store at 2-8 C.  
 
Sample Buffer 
8 M Urea 1.83 mL 
Urea Gel Buffer 167.0 uL 
0.5 M DTT 40.0 uL 
Saturated Sucrose 100 uL 
0.2% Bromophenol Blue 40.00 uL 
0.4 M EDTA 1.00 uL 
N.B. Make fresh on day of sample prep. 
Sample Denaturation 
1. Pipet 0.5 mL Acetone-Based Protein Precipitation Solution into as many 
microcentrifuge tubes as you have muscle samples (pre-labeled), and freeze in 
liquid N2 
2. Measure frozen weight of muscle sample (~10 mg for EDLs) and record 
3. Remove microcentrifuge tube from N2, open lid and place on ice 
4. Introduce muscle preparation (with sutures removed) to the microcentrifuge tube 
of frozen Acetone-Based Protein Precipitation Solution slurry, as it forms a slurry 
when warming up to about -35°C on ice 
5. Remove the tubes from ice and allow them to come to room temperature 
Sample Homogenization 
1. Transfer each denatured muscle sample (tissue only, no liquid) to a ground glass 
homogenizing tube, and pipet in 0.5 mL Water-Based Protein Precipitation 
Solution  
2. Homogenize muscle sample thoroughly 
3. Transfer the homogenate to a microcentrifuge tube by pouring – samples may sit 
on ice for 10 mins or more 
4. Centrifuge at 2000 RPM for 3 minutes at room temperature – do not over pack the 
protein pellet or resuspension will be difficult 
5. Discard the supernatant by pouring off into a waste beaker 
6. Wash pellet with 0.5 mL of ether, 3 times for 5 minutes each to remove TCA 
7. Let residual ether evaporate from the tube for 5 minutes in the hood or blow 
gently into the tube if you are impatient 
8. DO NOT let the pellet go totally dry or resuspension will be difficult 
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Resuspension 
1. Add 30 µL of urea sample buffer per mg frozen tissue weight  
2. Vortex and manually disperse the pellet if necessary 
3. pH should be around 9, check by confirming blue colour of the sample – if 
yellow/green at 2 M Tris base (pH 11) 1 µL at a time until colour becomes 
uniform between samples 
4. Add ~__mg of urea to microcentrifuge tube that contains 300 µL of sample buffer 
5. Shake samples for 15 minutes at RT, adding more urea if the others have 
dissolved 
6. Repeat until same is saturated by urea – do NOT oversaturate or the sample will 
become solid and unusable 
7. Store at -80°C if you do not use immediately.  
8. Thaw samples on day of use in an ice bath, and mix after 1 hr of thawing 
9. Do not heat urea samples on thawing – this can lead to breakdown of urea at high 
pH to cyanide with carbamylation of protein, which changes charge.  
Hand Casting of Polyacrylamide Gels 
10% (w/v) APS 
Ammonium persulfate (A3574) 0.10 g 
dH2O 1.0 mL 
N.B. Make fresh when casting gels. 
 
Urea/Glycerol Polyacrylamide Gels (2) 
dH2O 4.2 mL 
Glycerol (G5516) 9.0 mL 
30% Acrylamide/Bis 29:1 7.5 mL 
Urea Gel Buffer 1.9 mL 
Stir 10 mins under vacuum to degas  
10% APS 100 uL 
TEMED 10 uL 
Mix By Swirling  
Quickly pour into minigel apparatus & insert combs 
N.B. Make just prior to pouring. Gel starts polymerizing immediately after APS and 
TEMED are introduced to the solution – have everything ready to cast before adding 
these and move quickly. 
 
1. Place magnetic stir bar in small vacuum flask   
2. Mix dH2O, glycerol, acrylamide, and urea gel buffer in flask 
3. Close flask and turn on vacuum 
4. Stir for 10-15 minutes under vacuum to degas the solution 
5. Prepare plates/combs for casting 
6. Pour degassed solution into 50 mL falcon tube 
7. Draw 100 uL of 10% APS and 10 µL TEMED in pipettes 
8. Quickly add the APS and TEMED, mix by swirling – do NOT shake or you will 
regass the solution you just spent 15 minutes degassing 
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9. Cast gels using a disposable transfer pipet, pouring only into the centre of the 
plates – the solution will naturally spread and you do not need to move the pipet, 
as you may risk formation of bubbles 
10. Insert newly cleaned combs, and wipe up any spillage before polymerization - this 
protocol does not use a stacking gel 
11. Mix upper and lower buffers while gels polymerize  (~45 mins) 
Lower Buffer (1 L) 
Urea Gel Buffer 83.0 mL 
dH2O Q.S. to 1000 mL 
N.B. this buffer is poured into the electrophoresis tank. 
 
Upper Buffer (200 mL) 
DTT 73.3 mg 
Thioglycolate 53.3 mg 
Lower Buffer 200 mL 
N.B. this buffer is poured into the electrode assembly. 
 
Electrophoretic Separation of Proteins 
Pre-Electrophoresis 
1. Carefully remove combs from polymerized gel – it must be removed while 
remaining parallel to the gel to prevent damage to any wells 
2. Rinse wells with dH2O to remove any debris 
3. Rinse wells with Upper Buffer immediately before pre-electrophoresis 
4. Place gels into electrode assembly after wetting the gasket, ensuring that the 
plates are fully inserted into the brackets 
5. Check seal for leak using dH2O 
6. Pre-electrophorese at 400 V for 1 hour to force thioglycolate into the gel – this 
reduces any residual APS that was used to initiate polymerization, preventing 
protein oxidation which will effect protein migration 
Electrophoretic Separation of Proteins 
1. Load 5-20 µL of each sample – this gel system does not have a stacking gel so the 
tip of the pipet should be close to the gel in the well with slow addition of the 
sample. Urea and sucrose were added for increased density so the sample should 
layer in the well as a sharp band 
2. Amount to load depends on tissue source so optimal amount needs to be 
determined - Load at lease 5 µL to get good bands – if protein is too concentrated, 
sample can be diluted with urea sample buffer 
3. Do NOT use the end wells, as samples in the end wells tend to distort 
4. Electrophorese at 400 V for 85 minutes - Dye will run off gel but you can look at 
it during electrophoresis to make sure migration is normal 
5. Prepare 1X Transfer Buffer from 10X Transfer Buffer stock during 
electrophoresis – 1 L is enough for 1-2 gels  
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10X Transfer Buffer (1 L) 
1.9 M Glycine, 250 mM Tris, 0.5% (w/v) SDS 
Glycine  144.12 g 
Tris  30.29 g 
SDS 5.0 g 
dH2O 500 mL 
Dissolve  
dH2O Q.S. to 1 L 
N.B. Store at 2-8 C. 
 
Transfer Buffer (1 L) 
192 mM Glycine, 25 mM Tris, 0.05% (w/v) SDS 
10X Transfer Buffer  100 mL 
100% Methanol 200 mL 
dH2O 700 mL 
N.B. Make from concentrated stock on the day of transfer. 
 
Transferring Protein From Polyacrylamide Gel to the Nitrocellulose Membrane 
1. Cut ~8.5 x 7.0 cm pieces of nitrocellulose paper (0.45 mm pore size) 
2. Pour 1x Transfer Buffer into trays in preparation for blotting sandwich 
3. Disassemble electrode assembly, and remove gel cassettes 
4. Separate plates using green plastic wedge  
5. Cut off approximately one quarter of the upper part of gel 
6. Notch the upper left corner of the gel to aid in discerning orientation later 
7. Rinse gels gently in transfer buffer for 5 minutes to equilibrate 
8. Place a magnetic stirbar into the transfer tank, half fill with cooled 1X Transfer 
Buffer and position on stirrer 
9. Immerse nitrocellulose membrane in transfer buffer for 1 minute to wet it – it 
should be pre-notched in the upper left corner of the membrane to match the 
orientation of the gel 
10. With the black (cathode) side of the gel holder cassette submerged in Transfer 
Buffer, assemble the blotting sandwich in the following order, wetting each layer 
before its addition: sponge, blotting paper, gel, nitrocellulose membrane, blotting 
paper and sponge 
11. Roll after adding each layer to remove any air bubbles – having enough Transfer 
Buffer in the tray to cover all layers will help when removing bubbles 
12. Close the cassette, slide white latch to lock, and place into blotting module with 
the latch side up, and the black side of the cassette facing the black side of the 
blotting module 
13. Repeat for any additional blots, then place the blotting module with the gel holder 
cassettes into the tank 
14. Insert icepack into tank, add transfer buffer to the tank until the fill line is reach, 
and begin stirring 
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15. Place lid on top of the cell, connect cables to power supply, turn on power supply 
and transfer membrane at 25 V for 1 hour by selecting the pre-set method entitled 
“Transfer” 
 
Immunobloting 
Blocking of Non-Specific Sites 
1. Remove the nitrocellulose membrane from the blotting sandwich, and transfer to a 
square petri dish, ensuring that only the corner of the membrane is touched by 
tweezers and that the membrane remains protein-side up 
2. Wash the membrane in TBST three times for 10 minutes each 
3. Incubate with Blocking Buffer for 1 hour at room temperature to prevent non-
specific binding in a clean tray 
Primary Antibody Incubation 
1. Wash membrane in TBST twice, 5-10 min per wash 
2. Add 1:7,500 skMLCK polyclonal primary antibodies to fresh blocking buffer (i.e. 
1.5 µL in 10 mL) in a clean tray and incubate with rocking overnight at 4°C 
Secondary Antibody Incubation 
1. Remove primary antibody and wash the membrane with TBST, six times for 10 
minutes in a clean tray 
2. Incubate with secondary antibody, 1:10,000 dilution of Goat Anti-Rabbit IgG-
HRP in TBST (i.e 1 µL in 10 mL) for 1 hour in a clean tray 
Detection of Target Proteins 
1. Wash the membrane in TBST six times for 10 minutes 
2. Transfer membrane to a clean tray after rinsing with dH2O, and drip drying onto 
Kim Wipe 
3. Make detection buffer using equal volumes of ECL Prime luminol and oxidizing 
reagents 
4. Incubate the membrane in detection buffer for 2 minutes, constantly pipetting to 
cover entire membrane 
5. Decant the ECL Prime, lift membrane with tweezers and blot all excess reagent 
from the corner of the membrane using a Kim Wipe 
6. Cover membrane with sheet protector, and roll to remove air bubbles and/or 
excess liquid 
7. Turn on the CCD imaging machine – flip the power switches at the back of the 
unit (bottom right) and on the shelf 
8. Open the FluorChem application 
9. Place blot on imager platform and center on the screen, zoom if necessary 
10. Imager should be on setting 1 for chemiluminescence 
11. Select “Chemidisplay”, “Normal Sensitivity/Resolution”, and check “UV” for 
“Transluminator” and “Reflective” settings 
12. Select exposure time of 30-60 seconds, and select ‘Acquire Image’  
13. Save image to appropriate folder 
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10. Appendix III: 
Lyophilization of Muscle Tissue 
 
1. Turn lyophilizer on by switch on both the condenser and vacuum unit 
2. Press ‘Refridgeration – Auto’ and ‘Vacuum’ buttons 
3. Close all valves on the tree 
4. Ensure digital temperature and pressure gauges begin to drop 
5. Pour liquid N2 into thermoflask from storage dewar 
6. Remove samples from -80°C freezer and place in N2  
7. Transfer samples into ventilated microcentrifuge tubes (if not in one already) 
ensuring they stay frozen 
8. Precool LABCONCO 600 mL evacuation vessel with liquid N2 in a metal bowl 
9. Place samples in vessel, submerging the bottom of the flask in N2 
10. Close vessel with rubber top 
11. With the vessel still sitting in liquid N2, attach the metal tube to the vacuum tree 
12. When a good seal has been made, open valve and the vessel should evacuate (very 
obvious to both see and hear) 
13. Let machine run for minimum of 6 hours or over night (if you trust leaving it 
alone) 
14. Check occasionally to ensure it is running properly 
15. Shut machine down when finished 
16. Store the lyophilized samples in -80°C in a box with desiccant if not extracting 
immediately 
17. Open the circular lid of the condenser and allow it to return to room temperature 
18. Wipe up condensation from the inside of the condenser after room temperature 
has been reached 
19. Sign the log including name, date, usage etc.  
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11. Appendix IV: 
Metabolite Extraction 
Often the preparation of the tissue is the most critical. In the case of metabolite 
assays, the most hazardous period is usually the period between the experimental 
stimulus and the moment the enzyme activity is finally stopped. Rapid freezing is 
essential; therefore, most metabolite analysis is performed on extracts prepared from 
frozen tissue. Most metabolites are assayed in protein-free extracts prepared with 
perchloric acid (HClO4). HClO4 is preferred because most of it can be easily removed by 
precipitation as a potassium salt. All of the following analyses are performed on freeze-
dried tissue. Not only does it circumvent the problem of changing water contents in 
tissue, but also because the tissue is much easier to work with. Enzymes are rendered 
inactive in a water-free environment, and will remain so until water is re-added. 
Therefore, the weighing of the samples can be performed at room temperature and the 
tissue can be dissected free of connective tissues and blood.  
 
Required Solutions 
0.5 M PCA (500 mL) 
70% w/v Perchloric acid  21.55 mL 
dH2O 125 mL 
Mix  
dH2O Q.S. to 500 mL 
N.B. Store at 0-­‐4  ℃ for up to 1 month; 70% PCA stored under fume hood. 
 
1. In fume hood, pour PCA into small (>50 mL) beaker 
2. Measure 21.6 mL of PCA in 25 mL graduated cylinder 
3. Add 21.6 mL PCA to 125 mL dH2O in 500 mL graduated cylinder 
4. Rinse 25 mL graduated cylinder with dH2O into 500 mL graduated cylinder 
5. Bring to 500 mL with dH20 
6. Store in fridge (0-4ºC) for up to 1 month 
 
 
2.3 M KHCO3 
Potassium bicarbonate (237205) 2.3 g 
dH2O 5 mL 
Dissolve  
dH2O Q.S. to 10 mL 
N.B. Make fresh on day of extraction.   
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1. Weigh out 2.3 g KHCO3 
2. Measure ~5mL dH2O in small graduated cylinder   
3. Add to small amount of distilled H2O 
4. Bring to 10.0 mL 
5. Make fresh on day of extraction 
 
Confirm Neutral pH 
1. Calibrate the pH meter 
2. Combine 4 mL PCA and 1 mL KHCO3  
3. Measure and record pH - values between 6.5 and 7.5 are acceptable 
 
Perchloric Acid Metabolite Extraction Procedure 
1. Freeze dry tissue (overnight to ensure all water is removed) 
2. Store with dry rite in freezer until powdering 
3. Tease out connective tissue and powder 
4. Place in pre-weighed 12x75 glass centrifuge tube and weigh (~2.5  𝑚𝑔) 
5. Place tubes in an ice bucket (make sure tubes remain cold) 
6. Add 300 µL of pre-cooled 0.5 M PCA 
7. Extract for 15 minutes, vortexing several times and ensure all tissue is in contact 
with PCA 
8. Centrifuge for 10 minutes at 15000 G and 4°C– the glass tubes are compatible 
with the S4180 rotor (spinning helps remove some of the enzymes that can 
influence concentration) 
9. Remove 270 µL, aliquot to micocentrifuge tube and place in freezer (-20ºC) for 
10 min 
10. To the frozen supernatant add 67.5 µL of 2.3 M KHCO3 and vortex until liquid 
(addition of KHCO3 to a frozen supernatant prevents foaming over) 
11. Centrifuge for 10 min 0ºC at 15 000 G – the microcentrifuge tubes are compatible 
with the F2402H rotor - Potassium salt will precipitate. 
12. Remove supernatant, aliquot to new pre-labeled microcentrifuge tubes – this is the 
extraction that will be assayed for metabolites. 
 
Using the Centrifuge 
1. Power on the unit by flicking the black switch on the back of the unit 
2. When centrifuging, ensure that it is completely balanced and samples of the same 
volume are placed “across the street” from one another 
3. Different rotors are used for different sized tubes and are stored in the drawer 
directly underneath the unit 
4. To change rotor, remove central bolt and remove the current rotor, replace with 
the required rotor and replace and tighten the central bolt – this bolt does not need 
to be tightened with a ton of force, snug is fine. Program the correct rotor. 
5. Press “Enter” after making any changes to the settings 
6. Always turn unit off when you are finished and leave lid open 
7. Record use of the unit on the tracking sheet attached to the side  
   116 
12. Appendix V: 
Fluorometric Assays 
Pyridine nucleotides are natural oxidizing and reducing agents in a wide variety of 
enzyme systems. In the reduced form the nucleotide NADH/NADPH is fluorescent while 
in its oxidized form (NAD/NADP) it is not. The reduced form is also capable of 
fluorescent emission at 460nm when excited at 340nm. Due to these two physical 
properties, reactions can be quantified based directly on the change in the oxidative state 
of these coenzymes. Therefore the limiting factor, in the conversion of any of the 
metabolites, and production of the fluorescent material, NADH/NADPH, will be the 
amount of metabolite in the muscle because all other substrates/cofactors/enzymes in the 
assay are in excess. The presence of certain compounds in the assay, removes certain 
substrates, essentially forcing all reactions to occur one direction. Therefore the amount 
of fluorescence determined using the fluorometer is directly proportional to the amount of 
the metabolite in the muscle. 
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Muscle Adenosine Triphosphate (ATP) and Phosphocreatine (PCr) Assay 
 
P-Creatine + ADP 
          Creatine Kinase          
 Creatine + ATP  
 
ATP + Glucose 
          Hexokinase            
ADP + Glucose-6-P  
 
Glucose-6-P + NADP+ 
Glucose-6- Dehydrogenase
 6-P-Glucanolactone + NADPH  
 
Reagent Storage Stock Conc. 
Final 
Conc. 
Volume 
in  
25 mL 
Volume 
in 
50mL 
Volume 
in 
100mL 
1. Tris Buffer 
Trizma Base 
(T1503) 
Room 
Temp 
(Shelf) 
1.00  M 50.0  mM 1.25  mL 2.50  mL 5.00  mL 
2. MgCl2 
Magnesium 
Chloride 
(M8266) 
Room 
Temp 
(Shelf) 
1.00  M 1.00  mM 25.00  µμL 50.00  µμL 100.00  µμL 
3. DTT 
Dithiothreit
ol 
(D0632) 
2− 8  ℃   
 
(Fridge) 
0.50  M 0.5  mM 25.00  µμL 50.00  µμL 100.00  µμL 
4. Glucose 
(G8270) 
Room 
Temp 
(Shelf) 
100.00  mM 100.00  µμM 25.00  µμL 50.00  µμL 100.00  µμL 
5. NADP 
(N5755) 
−20  ℃  
(Freezer
) 
50.0  mM 50.0  µμM 25.00  µμL 50.00  µμL 100.00  µμL 
6. G-6-P-DH 
(G5760) 
2− 8  ℃   
(Fridge) 
4920  U/ml 0.03  U/mL 1.00  µμL 2.00  µμL 4.00  µμL 
7. ADP 
(A2754) 
−20  ℃  
(Freezer
) 
Solid − − − − 
8. Creatine 
Kinase 
(C3755) 
−20  ℃  
(Freezer
) 
324  U/mg − − − − 
9. Hexokinase 
(H4502) 
−20  ℃  
(Freezer
) 
130 U/mg − − − − 
Note: Mix reagents 1-5 together. Bring to volume with dH2O and adjust to pH 8.1. Then 
add reagent 6. Mix by inversion with enzymes. 
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Preparation of Dilute Enzyme 
 
For PART 2: Mix 2.5 µL of Hexokinase with 1.0 ml of buffer (for each plate). Mix by 
inversion. CAREFUL NOT TO FOAM 
 
For PART 3. Mix ~1.5 mg of phosphocreatine kinase and 5 mg of ADP into 5 ml of 
buffer.  Mix by inversion. 
 
Procedure for Assay (Note: Run everything in triplicate) 
 
Ensure you vortex each sample before pipetting 
Part 1.  
1. Fill first three wells – A1, A2 and A3 - with 10.00  𝜇𝐿 of dH2O per well 
2. Fill the next five rows of wells with 10.00𝜇𝐿 of varying concentrations of ATP      
Standard 
B1, B2 and B3 0.05  mM 
C1, C2 and C3  0.1  mM 
D1, D2 and D3 0.2  mM 
E1, E2 and E3 0.3  mM 
F1, F2 and F3 0.4  mM 
3. Fill the next five rows of wells with 10.00  𝜇𝐿 of varying concentrations of the  
PCr standard.   
(0.08  mM, 0.16  mM, 0.32  mM, 0.64  mM, 0.96  mM) 
4. Add 10.00  𝜇𝐿 of sample to the appropriate wells 
5. Add 185  𝜇𝐿 of buffer to each well 
7.   Incubate the plate for 25 minutes (if time permits - probably not necessary) 
6. Read the plate at sensitivity of 80 (Ex/Em 340nm/460nm) (base line reading = R1) 
 
Part 2.  
1. Add 6  𝜇𝐿 of dilute Hexokinase to all of the wells  
2. Incubate in the dark drawer for ~80 minutes (can also track by multiple measures) 
3. Read the plate (Ex/Em 340nm/460nm) 
     (𝑅2− 𝑅1 =   𝑟𝑒𝑓𝑙𝑒𝑐𝑡𝑠  𝐴𝑇𝑃  𝑖𝑛  𝑒𝑥𝑡𝑟𝑎𝑐𝑡) 
 
Part 3.  
1. Add 6  𝜇𝐿 of dilute Creatine Kinase to all of the wells 
2. Incubate in the dark drawer for ~120 minutes 
3. Read the plate (excitation setting 340, emission setting 460) 
       (𝑅3− 𝑅2 =   𝑟𝑒𝑓𝑙𝑒𝑐𝑡𝑠  𝑃𝐶𝑟  𝑖𝑛  𝑒𝑥𝑡𝑟𝑎𝑐𝑡) 
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ATP (A7699) Standard Curve  
To make fresh 2.0 mM solution: 5.69 mg ATP into 5 mL dH2O  
 
Concentration (mM) Stock Volume (µL) dH2O Volume (µL) Dilution Factor 
0.05 25 975 40.0 
0.1 50 950 20.0 
0.2 100 900 10.0 
0.3 150 850 6.67 
0.4 200 800 5.00 
 
 
Phosphocreatine (P7936) Standard Curve 
Stored in 8.0 mM aliquots in the -80ºC  
To make 8.0 mM stock: 21.85 mg phosphocreatine into 10 mL dH2O 
 
Concentration (mM) Stock Volume (µL) dH2O Volume (µL) Dilution 
0.08 10 990 100.0 
0.16 20 980 50.0 
0.32 40 960 25.0 
0.64 80 920 12.5 
0.96 120 880 8.3 
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Muscle Creatine (Cr) Assay 
 
Creatine + ATP                           Creatine Kinase                      P-Creatine + ADP  
  ADP + Phophopyruvate                       Pyruvate Kinase                                ATP + Pyruvate 
 
Pyruvate + NADH 
Lactate Dehydrogenase (LDH)
 Lactate + NAD  
 
Reagent Storage Stock Conc. 
Final  
Conc. 
Volume  
250 mL 
Volume 
50mL 
Volume 
100mL 
1. Imidazole 
(I0250) 
Room 
Temp 1.00  M 50  mM 1.25  mL 2.50  mL 5.00  mL 
2. MgCl2 
Magnesium 
Chloride 
(M8266) 
Room 
Temp 1.00  M 5.0  mM 125.00  µμL 250.00  µμL 500.00  µμL 
3. KCl 
Potassium 
Chloride 
(P9541) 
Room 
Temp 1.00  M 30.00  mM 0.75  mL 1.5  mL 3.00  mL 
4. PEP 
Phosphoenolpyr
uvate 
(P7002) 
−20  ℃  
(Freezer
) 
10.0  mM 25.0  µμM 60.0  µμL 120.00  µμL 240.00  µμL 
5. ATP 
(A2383) 
−20  ℃  
(Freezer
) 
SOLID 200.0  µμM 3.27  mg 6.54  mg 13.08  mg 
6. NADH 
(N8129) 
−20  ℃  
(Freezer
) 
15.0  mM 45  µμM 75.00  µμL 150.00  µμL 300.00  µμL 
7. LDH 
(L2500) 
2 − 8  ℃  
(Fridge) 
5264  U/mL 0.24  U/mL 1.10  µμL 2.3  µμL 4.6  µμL 
8. Pyruvate 
Kinase 
(P1506) 
2 − 8  ℃  
(Fridge) 
1252  U/mL 0.75  U/mL 15.00  µμL 30.00  µμL 60.00  µμL 
9. Creatine 
Kinase 
(C3755) 
−20  ℃  
(Freezer
) 
324  U/mg 3.6  U/mL − − − 
Note: Mix reagents 1-6 together. Bring to volume with distilled water and adjust to pH 7.5. Then 
add reagents 7 & 8. Mix by inversion when enzymes added. 
 
 
Preparation of Dilute Enzyme 
 
For step 2. Mix 1.0 mg of Creatine Kinase with 2.6 ml of buffer. Mix by inversion. 
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Before beginning to pipette the samples you must test the fluorescence of the buffer 
(might have to change gain) 
 
Procedure for Assay 
 
Part 1.  
1. Fill three wells with a blank (10.00 µL dH2O per well) 
2.   a. Vortex each concentration mixture before pipetting 
 b. Fill the next five wells with 10.00µL of varying concentrations of Cr standard 
(0.1mM, 0.2 mM, 0.4 mM, 0.8 mM, 1.2 mM) 
3.  a. Vortex each sample before pipetting 
b. Add 10.00 µL of sample to the appropriate wells 
4. Add 185 µL of buffer to each well 
5. Incubate for 30 minutes  
6. Read the plate at a sensitivity of 100 (excitation setting 340, emission setting 460) 
(base line reading) 
 
Part 2.  
 
1. Add 6 µL of dilute Creatine Kinase to all of the wells  
2. Place in the dark for 55 minutes 
3. Read the plate (excitation setting 340, emission setting 460) 
 
Note: Everything analyzed in triplicate 
 
Creatine (Sigma C0780-50g) Standard Curve 
Stored in 10 mM aliquots in the -80ºC 
To make 10 mM stock: 131.1 mg into 100 ml dH2O 
 
Concentration (mM) Stock Volume (µL) dH2O Volume (µL) Dilution Factor 
0.1 10 990 100 
0.2 20 980 50 
0.4 40 960 25 
0.8 80 920 12.5 
1.2 120 880 8.33 
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Muscle Lactate Assay 
Lactate+ NAD+   !"#$"$%  !"!!"#$%&'()&     pyruvate+ NADH+ H+ 
 
 
Pyruvate+ Hydrazine                                                                                                        Pyruvate Hydrazone 
 
Reagent Stock Conc. 
Final 
Conc. 
Volume  
250 mL 
Volume 
50mL 
Volume 
100mL 
1. Hydrazine 1.00  𝑀 100.0  𝑚𝑀 2.50  𝑚𝐿 5.00  𝑚𝐿 10.00  𝑚𝐿 
2. Glycine 1.00  𝑀 100.0  𝑚𝑀 2.50  𝑚𝐿 5.00  𝑚𝐿 10.00  𝜇𝐿 
3. NAD+ 100.0  𝑚𝑀 0.5  𝑚𝑀 125  𝜇𝐿 250  𝜇𝐿 500.00  𝜇𝐿 
4. LDH 5264  𝑈/𝑚𝐿 8.00  𝑈/𝑚𝐿 − − − 
Note: Mix reagents 1-3 together. Bring to volume with dH2O and adjust to pH 10. 
 
Preparation of Dilute Enzyme 
 
Add 17.25 µL of LDH (L2500) to 1.0 mL of reagent. 
 
Procedure for Assay 
 
Part 1.  
1. Fill three wells with a blank (10.00 µL dH2O per well) 
2.   a. Vortex each concentration mixture before pipetting 
 b. Fill the next five wells with 10.00µL of varying concentrations of lactate 
standard (0.025 mM, 0.05 mM, 0.1 mM, 0.2 mM, 0.8 mM) 
3.  a. Vortex each sample before pipetting 
b. Add 10.00 µL of sample to the appropriately wells 
4. Add 185 µL of buffer to each well 
5. Incubate for 15 minutes  
6. Read the plate at a sensitivity of 120 (Ex/Em 340nm/460nm) (base line reading) 
 
Part 2.  
 
1. Add 10 µL of dilute LDH to all of the wells  
2. Place in the dark for 120 minutes 
3. Read the plate (excitation setting 340, emission setting 460) 
 
Note: Run everything in triplicate 
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Lactate Standard Curve 
Pre-made lactate standard (4.44 mM) 
 
Conc (mM) Stock (µL) dH2O (µL) 
0.1 23 977 
0.2 45 955 
0.4 90 910 
0.8 180 820 
1.2 270 730 
 
 
Conc (mM) Stock (µL) dH2O (µL) 
0.025 5.6 994 
0.05 11.25 988 
0.1 22.5 978 
0.2 45 955 
0.8 180 820 
 
 
 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛  𝐹𝑎𝑐𝑡𝑜𝑟  (𝐷𝐹) =    𝑡𝑜𝑡𝑎𝑙  𝑣𝑜𝑙𝑢𝑚𝑒𝑠𝑎𝑚𝑝𝑙𝑒  𝑣𝑜𝑙𝑢𝑚𝑒 
  
 𝐷𝐹!"!#$ =   𝐷𝐹!    ∙   𝐷𝐹!  
 
 𝐷𝐹!   =    𝑇𝑜𝑡𝑎𝑙  𝑉𝑜𝑙𝑢𝑚𝑒𝑆𝑎𝑚𝑝𝑙𝑒  𝑉𝑜𝑙𝑢𝑚𝑒     = 𝑣𝑜𝑙𝑢𝑚𝑒  𝑜𝑓  𝑃𝐶𝐴   𝜇𝐿 +𝑚𝑢𝑠𝑐𝑙𝑒  𝑚𝑎𝑠𝑠  (𝜇𝐿)  𝑚𝑢𝑠𝑐𝑙𝑒  𝑚𝑎𝑠𝑠  (𝜇𝐿)   
 
 𝐷𝐹!   =  = 𝑣𝑜𝑙𝑢𝑚𝑒  𝑜𝑓  𝑆𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡   𝜇𝐿 + 𝑣𝑜𝑙𝑢𝑚𝑒  𝑜𝑓  𝐾𝐻𝐶𝑂!(𝜇𝐿)𝑣𝑜𝑙𝑢𝑚𝑒  𝑜𝑓  𝑆𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡  (𝜇𝐿)   
 
